{"meta":{"query_hash":"454ddb1c1797","filters":{"venue":"Neurology Neuroimmunology & Neuroinflammation"},"cohort_total":68,"direct_labels_cover":0,"predictions_cover":68,"exported":68,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/454ddb1c1797","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neurology+Neuroimmunology+%26+Neuroinflammation"},"results":[{"id":"W2123878928","doi":"10.1212/nxi.0000000000000035","title":"Transient neonatal autoimmune autonomic ganglionopathy","year":2014,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Autonomic nervous system; Neuroscience; Pure autonomic failure; Acetylcholine; Acetylcholine receptor; Autonomic ganglion; Nicotinic agonist; Medicine; Immunology; Receptor; Biology; Endocrinology; Internal medicine; Heart rate; Blood pressure","score_opus":0.00809733013863895,"score_gpt":0.21928991356482383,"score_spread":0.21119258342618488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123878928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81767493,0.03826962,0.017199816,0.007580191,0.001738792,0.00032548734,0.0015061545,0.0020075052,0.11369757],"genre_scores_gemma":[0.9839422,0.005116126,0.0010695645,0.0017091933,0.00029040166,0.000068612644,0.0002586213,0.000046223955,0.0074991267],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997218,0.000034749304,0.000020172265,0.000053994645,0.000074003496,0.00009529554],"domain_scores_gemma":[0.9994918,0.0001443744,0.00011658781,0.00005240576,0.00005896084,0.00013573264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002729352,0.0004727812,0.0005442068,0.00041017035,0.00047275235,0.00038406462,0.0005285978,0.00081595045,0.0037882351],"category_scores_gemma":[0.0019406972,0.000095357245,0.00031017757,0.00035117718,0.0005409858,0.00046609435,0.00042675145,0.0014468665,0.00072697713],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036415,0.00011954824,0.037689924,0.00047120085,0.000051444527,0.88349164,0.00029886677,0.00045351236,0.009126499,0.003773142,0.003742749,0.060417328],"study_design_scores_gemma":[0.000031433912,0.00045303724,0.055989232,0.00031374866,0.00007088249,0.9231483,0.00018665647,0.0007020727,0.006714966,0.0010702912,0.011294732,0.000024731818],"about_ca_topic_score_codex":0.0025882008,"about_ca_topic_score_gemma":0.0018704757,"teacher_disagreement_score":0.0037882351,"about_ca_system_score_codex":0.0012409248,"about_ca_system_score_gemma":0.0006224384,"threshold_uncertainty_score":0.012672901},"labels":[],"label_agreement":null},{"id":"W2198811857","doi":"10.1212/nxi.0000000000000104","title":"B lymphocytes in neuromyelitis optica","year":2015,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"National Eye Institute; Chugai Pharmaceutical; Novartis Pharma; Genentech; Multiple Sclerosis Society; Myelin Repair Foundation; National Institutes of Health; Guthy-Jackson Charitable Foundation; Questcor Pharmaceuticals; Biogen; U.S. Department of Defense; Sanofi; Pfizer; Eli Lilly and Company; Myasthenia Gravis Foundation of America; Deutsche Forschungsgemeinschaft; National Multiple Sclerosis Society; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; U.S. Department of Veterans Affairs; Alnylam Pharmaceuticals","keywords":"Neuromyelitis optica; Autoantibody; Immunology; Aquaporin 4; Astrocyte; Pathogenesis; B cell; Proinflammatory cytokine; Autoimmunity; Medicine; Autoimmune disease; Inflammation; Biology; Neuroscience; Antibody; Pathology; Central nervous system","score_opus":0.10842968246215468,"score_gpt":0.38110926550645097,"score_spread":0.2726795830442963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198811857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059072023,0.99930644,0.00002314419,0.000105904204,0.0000834813,0.0000025664342,0.000008308944,0.00000220987,0.00040879793],"genre_scores_gemma":[0.0004903221,0.9989336,0.000055633493,0.00011255812,0.00008938205,0.000004008458,0.000014780839,5.509998e-7,0.0002990538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998323,0.000034467965,0.000035042623,0.000027289347,0.000056437475,0.000014383727],"domain_scores_gemma":[0.99972445,0.0001308932,0.000051355986,0.0000066001876,0.000064371045,0.000022273658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051023165,0.0007614684,0.0012386645,0.0037584228,0.0002786894,0.00092994963,0.0007095284,0.001090832,0.00438381],"category_scores_gemma":[0.0007879125,0.000271413,0.00046251228,0.0027208754,0.00044844448,0.0010706084,0.00065390876,0.0010372862,0.0020684288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000956103,0.000046564353,0.0003014455,0.031653836,0.00012439136,0.00030963,0.00008772465,0.00016458947,0.00084702513,0.0019166516,0.027717005,0.9367355],"study_design_scores_gemma":[0.000036052857,0.00008306107,0.0015109202,0.010288563,0.00021614252,0.0028678956,0.00010207016,0.00003675069,0.00033573172,0.0017144922,0.9827908,0.000017667764],"about_ca_topic_score_codex":0.0015380739,"about_ca_topic_score_gemma":0.002298488,"teacher_disagreement_score":0.00438381,"about_ca_system_score_codex":0.0005270668,"about_ca_system_score_gemma":0.0010887313,"threshold_uncertainty_score":0.014665306},"labels":[],"label_agreement":null},{"id":"W2282937261","doi":"10.1212/nxi.0000000000000206","title":"Degos disease mimicking primary vasculitis of the CNS","year":2016,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Children's Hospital of Philadelphia; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Biogen; Multiple Sclerosis Scientific Research Foundation; Teva Pharmaceutical Industries; Eli Lilly and Company; Sanofi; University of Oxford; National Multiple Sclerosis Society","keywords":"Medicine; Vasculitis; Headaches; Hemiparesis; Radiology; Magnetic resonance imaging; Magnetic resonance angiography; Angiography; Circle of Willis; Pathology; Disease; Surgery","score_opus":0.014279688206939277,"score_gpt":0.22892096354507785,"score_spread":0.21464127533813857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282937261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845723,0.0017430651,0.00056457135,0.00028875135,0.000094206196,0.000092031194,0.00017834707,0.0000787162,0.012388003],"genre_scores_gemma":[0.99789643,0.0007345935,0.0002950323,0.0001533417,0.00008412694,0.00001161566,0.000072766656,0.000006844056,0.00074528967],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997274,0.000026585647,0.000020431335,0.00006164735,0.00003224106,0.0001316726],"domain_scores_gemma":[0.9995302,0.00012774921,0.000097622695,0.000030154406,0.00003430525,0.00018001923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018867689,0.0014408126,0.0006851873,0.0011111657,0.001048609,0.0006800324,0.00035868073,0.0009942893,0.00332658],"category_scores_gemma":[0.0010587132,0.00060760375,0.00034049572,0.00054390007,0.0008423939,0.00070730754,0.0005712237,0.00083332,0.0008396771],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014954942,0.00012715562,0.04795682,0.00009485076,0.000014503876,0.9442811,0.00028527516,0.000117729665,0.00434594,0.0002986028,0.00041929897,0.0019091615],"study_design_scores_gemma":[0.0000595087,0.00040532445,0.04924117,0.000033724667,0.000033246713,0.94701695,0.00019805631,0.0003960397,0.0010226216,0.00030099147,0.0012827312,0.000009718086],"about_ca_topic_score_codex":0.002006245,"about_ca_topic_score_gemma":0.002848739,"teacher_disagreement_score":0.00332658,"about_ca_system_score_codex":0.0006747893,"about_ca_system_score_gemma":0.000477511,"threshold_uncertainty_score":0.011128485},"labels":[],"label_agreement":null},{"id":"W2509787928","doi":"10.1212/nxi.0000000000000277","title":"Restoring immune tolerance in neuromyelitis optica","year":2016,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Guthy-Jackson Charitable Foundation","keywords":"Neuromyelitis optica; Neuroscience; Immune system; Immunology; Medicine; Disease; Immune tolerance; Aquaporin 4; Bioinformatics; Biology; Multiple sclerosis; Pathology","score_opus":0.024126786713647812,"score_gpt":0.27792626443029284,"score_spread":0.253799477716645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509787928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018696114,0.9983576,0.00012189137,0.00021286817,0.00023806661,0.0000038281974,0.0000067402907,0.000006000991,0.0008660373],"genre_scores_gemma":[0.001171386,0.9972338,0.0002031518,0.00018089247,0.00024507893,0.0000068253066,0.000016972957,0.0000016110773,0.00094041316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998975,0.000016480762,0.000017447042,0.000017658123,0.000038418195,0.000012528114],"domain_scores_gemma":[0.99991274,0.000031095005,0.00001856479,0.0000033034535,0.00002108372,0.00001319451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034600412,0.0007070414,0.0007576398,0.0018318668,0.0002589056,0.00066185574,0.00046912653,0.00094754586,0.0015041778],"category_scores_gemma":[0.00031568718,0.00016162562,0.00027545186,0.0012738318,0.00039858793,0.0010112018,0.0006201613,0.0012672239,0.0014132331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058399513,0.000076437296,0.00014485855,0.0073568677,0.00002972867,0.00022919742,0.000058191697,0.0002376236,0.0028587794,0.003142788,0.018230358,0.96757674],"study_design_scores_gemma":[0.000014387567,0.00013847959,0.000982558,0.0019208934,0.000045675915,0.0026777722,0.00007199865,0.00008946884,0.00096796895,0.002071732,0.9910028,0.000016275908],"about_ca_topic_score_codex":0.0005621379,"about_ca_topic_score_gemma":0.001008613,"teacher_disagreement_score":0.0018318668,"about_ca_system_score_codex":0.00040349946,"about_ca_system_score_gemma":0.00059298764,"threshold_uncertainty_score":0.005032003},"labels":[],"label_agreement":null},{"id":"W2597919924","doi":"10.1212/nxi.0000000000000340","title":"Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis","year":2017,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"McGill University","keywords":"Apoptosis; CD8; In vivo; T cell; Cell; Programmed cell death; In vitro; Cytotoxic T cell; Biology; Immunology; Chemistry; Molecular biology; Cell biology; Immune system; Biochemistry; Genetics","score_opus":0.0382436734497531,"score_gpt":0.30568102827431387,"score_spread":0.26743735482456077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597919924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982128,0.00067404384,0.00074047066,0.000014535318,0.0000039240554,0.000013758206,0.0000751686,0.000015616057,0.00024980473],"genre_scores_gemma":[0.9994727,0.00009029266,0.00025263068,0.000011701348,0.0000034552293,0.000008374555,0.000062280815,0.000002292128,0.000096270516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979347,0.00009294503,0.00002257817,0.0000338859,0.00003277616,0.000024445906],"domain_scores_gemma":[0.9997495,0.0001023524,0.00008328361,0.00002250821,0.000021908862,0.000020400164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004925829,0.00024005256,0.00032678514,0.00025947817,0.00013532682,0.0001787024,0.00011856571,0.00015747515,0.0008505548],"category_scores_gemma":[0.0006583943,0.00013905065,0.00024537137,0.00013252105,0.0001601483,0.00012732708,0.00014806207,0.0002208111,0.00012118868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011421884,0.00029483772,0.19017555,0.00039699016,0.00031350792,0.0017303952,0.00030364707,0.0030424956,0.7502974,0.00024773355,0.00024612612,0.04152939],"study_design_scores_gemma":[0.00053878746,0.014557043,0.6039255,0.00007433994,0.0007696176,0.012251427,0.00025214904,0.013251138,0.35047162,0.00052569876,0.0033551636,0.000027498278],"about_ca_topic_score_codex":0.00039101054,"about_ca_topic_score_gemma":0.00056544034,"teacher_disagreement_score":0.0008505548,"about_ca_system_score_codex":0.0002610454,"about_ca_system_score_gemma":0.00015539478,"threshold_uncertainty_score":0.0028454065},"labels":[],"label_agreement":null},{"id":"W2766659089","doi":"10.1212/nxi.0000000000000402","title":"MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS","year":2017,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"MERTK; Phagocytosis; Flow cytometry; Myelin; Microglia; Biology; Cell biology; Immunology; Receptor tyrosine kinase; Inflammation; Kinase; Endocrinology; Central nervous system","score_opus":0.007338399895011123,"score_gpt":0.20197246765468818,"score_spread":0.19463406775967707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766659089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992687,0.0003651491,0.00013450258,0.000011200784,0.0000035403737,0.0000084007115,0.0000645729,0.000003668208,0.00014017073],"genre_scores_gemma":[0.99901104,0.00021911635,0.0002114297,0.000017338829,0.000007122481,0.00002494159,0.00017940674,0.0000022053432,0.00032735878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998702,0.000023267312,0.000016719769,0.000032878546,0.000024810573,0.00003217547],"domain_scores_gemma":[0.9999118,0.00001531403,0.000027660823,0.000008934879,0.000016931572,0.000019359248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012644539,0.00018400901,0.00020700097,0.00019667973,0.00013174291,0.00021484637,0.00009686476,0.00020287512,0.0011598582],"category_scores_gemma":[0.00020392762,0.00008221405,0.000116425595,0.00011289476,0.00012308104,0.00009472601,0.00016487355,0.00018470053,0.00028083735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014296826,0.00010505558,0.019972207,0.00008609062,0.000017487602,0.0006619197,0.0002155656,0.00007554179,0.9725028,0.00005255582,0.000065489425,0.0048156357],"study_design_scores_gemma":[0.00027191182,0.004212716,0.3800122,0.00005153471,0.00010341596,0.010712339,0.00069398514,0.0010906268,0.598886,0.00016654657,0.0037806272,0.000018122866],"about_ca_topic_score_codex":0.0001875546,"about_ca_topic_score_gemma":0.00015935376,"teacher_disagreement_score":0.0011598582,"about_ca_system_score_codex":0.000104951905,"about_ca_system_score_gemma":0.0000892457,"threshold_uncertainty_score":0.0038800836},"labels":[],"label_agreement":null},{"id":"W2780348759","doi":"10.1212/nxi.0000000000000432","title":"Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod","year":2017,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dimethyl fumarate; Fingolimod; Flow cytometry; Lymphocyte; Immunology; Molecular biology; Chemistry; Medicine; Multiple sclerosis; Biology","score_opus":0.013191553727789532,"score_gpt":0.24046685271144042,"score_spread":0.2272752989836509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780348759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858093,0.00072458846,0.00010884064,0.000021565344,0.0000042487077,0.000011941027,0.00009608369,0.000006285582,0.0004455114],"genre_scores_gemma":[0.99941266,0.00013586279,0.00012838145,0.000036256468,0.000009578017,0.0000123811715,0.00012482938,0.0000014802071,0.00013862835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980944,0.000045023004,0.000030979914,0.0000501406,0.000035074085,0.000029381192],"domain_scores_gemma":[0.9997539,0.00006302206,0.00009403351,0.000010401441,0.000034061064,0.000044620083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025777603,0.00025039245,0.00039985313,0.00066114933,0.00027624113,0.0003372779,0.00013028464,0.00025836952,0.0010507741],"category_scores_gemma":[0.00063421036,0.0000928771,0.00018052185,0.00036175642,0.00015166092,0.00023656916,0.000177095,0.0002192486,0.00016641365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033122727,0.00013431146,0.9367855,0.000095880576,0.000088213405,0.0013284637,0.00034092367,0.00016753314,0.038823612,0.000031750737,0.00017066141,0.018720884],"study_design_scores_gemma":[0.00008997343,0.0024915196,0.9827321,0.00003370637,0.00011077438,0.0076144254,0.00033288475,0.00041764375,0.004917368,0.000049084305,0.0012008476,0.000009679534],"about_ca_topic_score_codex":0.00033028872,"about_ca_topic_score_gemma":0.0004013234,"teacher_disagreement_score":0.0010507741,"about_ca_system_score_codex":0.0001707075,"about_ca_system_score_gemma":0.00011214466,"threshold_uncertainty_score":0.003515184},"labels":[],"label_agreement":null},{"id":"W2783237032","doi":"10.1212/nxi.0000000000000436","title":"Quantitative spinal cord MRI in radiologically isolated syndrome","year":2018,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Oryzon Genomics; Teva Pharmaceutical Industries; Biogen; Sanofi; EMD Serono; National Multiple Sclerosis Society","keywords":"Medicine; Fractional anisotropy; Diffusion MRI; Spinal cord; Magnetic resonance imaging; White matter; Atrophy; Magnetization transfer; Nuclear medicine; Radiology; Internal medicine","score_opus":0.050883451435789914,"score_gpt":0.3403414783980208,"score_spread":0.2894580269622309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783237032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991804,0.00017617119,0.00028892254,0.000017678121,0.0000026561459,0.000008710164,0.00012618565,0.000011205199,0.00018807093],"genre_scores_gemma":[0.99913293,0.00006119184,0.0005395432,0.000018957793,0.0000064050837,0.000007433365,0.0001529041,0.0000042905885,0.00007638745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969566,0.00007961394,0.000046108973,0.000103984494,0.0000509466,0.000023687491],"domain_scores_gemma":[0.9991159,0.00021458972,0.00038063552,0.00006817186,0.0001184389,0.00010230461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007001021,0.0006222477,0.00033235576,0.0015079647,0.000292096,0.00043313784,0.000297487,0.00062468933,0.0025883534],"category_scores_gemma":[0.0022393174,0.00026070816,0.00032873903,0.00046569534,0.0005369208,0.00034550592,0.0005255653,0.00024132918,0.00024816266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012072433,0.0000904823,0.9604047,0.00016304734,0.00027578563,0.0021180394,0.00046519766,0.00022087776,0.027190864,0.00007527884,0.00016215647,0.007626379],"study_design_scores_gemma":[0.000017513807,0.00030092313,0.9946313,0.000021289627,0.00006322585,0.0030233352,0.00018504573,0.00032130946,0.0012631852,0.000063591404,0.00010289549,0.000006279503],"about_ca_topic_score_codex":0.0036385977,"about_ca_topic_score_gemma":0.0045129214,"teacher_disagreement_score":0.0036385977,"about_ca_system_score_codex":0.0002517951,"about_ca_system_score_gemma":0.00021382046,"threshold_uncertainty_score":0.008658946},"labels":[],"label_agreement":null},{"id":"W2891878956","doi":"10.1212/nxi.0000000000000499","title":"Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes","year":2018,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Brain Institute; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Interquartile range; Medicine; Dentate gyrus; White matter; Internal medicine; Hippocampus; Magnetic resonance imaging; Radiology","score_opus":0.030782241289427702,"score_gpt":0.31075791559167804,"score_spread":0.27997567430225034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891878956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999658,0.00010171825,0.000049890525,0.000009284655,9.5102877e-7,0.0000011454509,0.00011424215,0.000002748945,0.0000620524],"genre_scores_gemma":[0.9996755,0.0000466576,0.00008690035,0.0000045831825,0.0000021882506,0.000002082217,0.0001512961,0.0000011107762,0.00002969513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999843,0.000040393294,0.000017326543,0.000042907417,0.000032118583,0.000024324185],"domain_scores_gemma":[0.999161,0.00013141414,0.0005162569,0.000035117286,0.00005686226,0.00009947283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002633071,0.0002438554,0.00018441545,0.00036895456,0.00008574533,0.00022489297,0.00013442566,0.00017882888,0.0007703739],"category_scores_gemma":[0.0012229938,0.00012676326,0.00022853108,0.00041672622,0.00015583844,0.00021919364,0.00027330677,0.00021146596,0.00008469531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011949802,0.000012612271,0.9981275,0.0000062058734,0.000031439176,0.000042972013,0.00002324267,0.00007827147,0.00033208207,0.0000068014688,0.00003155106,0.0011878969],"study_design_scores_gemma":[0.0000026342534,0.000051910778,0.99951553,0.0000012808829,0.0000068651507,0.0001396457,0.000026626672,0.00015471203,0.00006434734,0.000007142311,0.000028592467,7.0936153e-7],"about_ca_topic_score_codex":0.0030437245,"about_ca_topic_score_gemma":0.0039635785,"teacher_disagreement_score":0.0030437245,"about_ca_system_score_codex":0.00016173291,"about_ca_system_score_gemma":0.00013865346,"threshold_uncertainty_score":0.006052017},"labels":[],"label_agreement":null},{"id":"W2895793418","doi":"10.1212/nxi.0000000000000516","title":"Case of alemtuzumab-related alopecia areata management in MS","year":2018,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Alemtuzumab; Medicine; Alopecia areata; Multiple sclerosis; Dermatology; Surgery; Internal medicine; Gastroenterology; Immunology","score_opus":0.011977028436390893,"score_gpt":0.25552710117490834,"score_spread":0.24355007273851745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895793418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94412935,0.018630764,0.009126254,0.0035580958,0.0008168015,0.0003846366,0.0002831992,0.0006926407,0.022378381],"genre_scores_gemma":[0.9936754,0.0014100061,0.0014541604,0.0007710473,0.00084887305,0.00003374605,0.00006885974,0.00003210118,0.0017058895],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992962,0.00009528676,0.00007113885,0.00016672263,0.00010427009,0.00026640372],"domain_scores_gemma":[0.9985991,0.0003756956,0.00033749157,0.00018316283,0.00012922866,0.00037523283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035602532,0.0017653839,0.0010867376,0.0020702868,0.002993946,0.0018355043,0.0012336511,0.004939977,0.0022342263],"category_scores_gemma":[0.0028581372,0.00085693586,0.0014527937,0.0017750182,0.001189962,0.0014477493,0.0014539652,0.002741243,0.0010146521],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035985162,0.000038235452,0.0031343268,0.00003333388,0.0000147577775,0.99353784,0.00016865994,0.00009003917,0.0007729961,0.00019087322,0.0002901739,0.0016927163],"study_design_scores_gemma":[0.000013977256,0.000035268105,0.0013156245,0.000013435452,0.000013175286,0.99673766,0.00006209433,0.00028417108,0.00048212428,0.00015486107,0.0008822398,0.00000538124],"about_ca_topic_score_codex":0.0012776325,"about_ca_topic_score_gemma":0.0012701899,"teacher_disagreement_score":0.004939977,"about_ca_system_score_codex":0.0009825741,"about_ca_system_score_gemma":0.00054367277,"threshold_uncertainty_score":0.007474184},"labels":[],"label_agreement":null},{"id":"W2945729689","doi":"10.1212/nxi.0000000000000576","title":"Age matters","year":2019,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CSF pleocytosis; Lumbar puncture; Confidence interval; Pleocytosis; Etiology; Pediatrics; Lumbar; Retrospective cohort study; Receiver operating characteristic; Internal medicine; Cerebrospinal fluid; Gastroenterology; Surgery","score_opus":0.04148222317102074,"score_gpt":0.3058954736056806,"score_spread":0.26441325043465985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945729689","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012547872,0.07061236,0.0018787044,0.11543894,0.03839301,0.00039097018,0.017920408,0.0012803472,0.74153745],"genre_scores_gemma":[0.1648573,0.085222766,0.0037528567,0.12750003,0.026549287,0.00073441985,0.013489241,0.0012957911,0.5765983],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749196,0.0007416056,0.00032426513,0.0004782078,0.0005873733,0.00037657187],"domain_scores_gemma":[0.99382883,0.0013916942,0.0009571527,0.00064900395,0.0021528213,0.0010205213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022923737,0.00051078445,0.00047093933,0.0014774379,0.0011733946,0.0035796342,0.00086427294,0.0017464843,0.27019852],"category_scores_gemma":[0.016304206,0.00025354818,0.0005583445,0.0015833186,0.0010691936,0.0034484628,0.0027677892,0.0017065177,0.122964926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000887359,0.000036886144,0.0118225375,0.0017593863,0.000044455945,0.00089928944,0.0012830637,0.000028937027,0.00026817908,0.011956121,0.7629799,0.20883244],"study_design_scores_gemma":[0.000008116091,0.000016911725,0.0044879243,0.00071238476,0.000013608171,0.00094302907,0.00052829337,0.0000063099224,0.00006525403,0.000981291,0.99223083,0.0000061819433],"about_ca_topic_score_codex":0.0026443063,"about_ca_topic_score_gemma":0.0029454373,"teacher_disagreement_score":0.27019852,"about_ca_system_score_codex":0.0010587419,"about_ca_system_score_gemma":0.0038115906,"threshold_uncertainty_score":0.9039041},"labels":[],"label_agreement":null},{"id":"W2954887335","doi":"10.1212/nxi.0000000000000590","title":"Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP","year":2019,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Japan Society for the Promotion of Science; Sanofi Genzyme; Novartis Pharma; Grifols; Ono Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma; Bayer Yakuhin; Celgene; Ministry of Education, Culture, Sports, Science and Technology; Pfizer Japan; Shionogi; Argenx; Ministry of Health, Labour and Welfare; Eisai; Japan Blood Products Organization; Boehringer Ingelheim Japan; Kissei; Neurocrine Biosciences; Pfizer; Biogen; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Heinrich-Heine-Universität Düsseldorf; Bristol-Myers Squibb; GBS/CIDP Foundation International; Teva Pharmaceutical Industries; Myasthenia Gravis Foundation of America; Bayer HealthCare; Kowa Company; Sanofi; CSL Behring","keywords":"Medicine; Chronic inflammatory demyelinating polyneuropathy; Adverse effect; Internal medicine; Polyradiculoneuropathy; Gastroenterology; Surgery; Antibody; Pediatrics; Immunology","score_opus":0.00639744829432481,"score_gpt":0.22983941409222605,"score_spread":0.22344196579790124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954887335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969072,0.002381838,0.00019471992,0.000037736623,0.000010042022,0.00004126813,0.00009112546,0.000013177174,0.00032306163],"genre_scores_gemma":[0.9988753,0.0004512163,0.00016543281,0.000059676568,0.00004213026,0.000041473253,0.00017964841,0.000002639404,0.00018237795],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99943596,0.00027621584,0.000045240977,0.00006343332,0.00011590474,0.00006316927],"domain_scores_gemma":[0.9984268,0.00045903935,0.00067857536,0.00012533828,0.0000982506,0.00021208229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019255027,0.0003710045,0.0006244287,0.00014829167,0.00015002611,0.00032728308,0.00037069654,0.0005160821,0.000948062],"category_scores_gemma":[0.0018479633,0.00012797756,0.0003573629,0.00014862363,0.00043027502,0.00047844157,0.00018823665,0.0007477265,0.00022897864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3651654,0.01729727,0.13577422,0.0011029043,0.0010875624,0.0009798456,0.000321277,0.0027145767,0.11834425,0.00015187301,0.0010467422,0.35601416],"study_design_scores_gemma":[0.03133637,0.6909948,0.24809545,0.00012282042,0.000739727,0.002292033,0.000106216714,0.0022907623,0.021402277,0.000120096396,0.0024621333,0.000037259375],"about_ca_topic_score_codex":0.0001459025,"about_ca_topic_score_gemma":0.00016105133,"teacher_disagreement_score":0.0019255027,"about_ca_system_score_codex":0.00023444544,"about_ca_system_score_gemma":0.0002950297,"threshold_uncertainty_score":0.010183156},"labels":[],"label_agreement":null},{"id":"W2968015278","doi":"10.1212/nxi.0000000000000598","title":"High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS","year":2019,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Biomarker; Transplantation; Gastroenterology; Expanded Disability Status Scale; Oncology; Multiple sclerosis; Pathology; Immunology","score_opus":0.012009847363095776,"score_gpt":0.24055037982645155,"score_spread":0.2285405324633558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968015278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873096,0.00038265315,0.00013635938,0.000026475267,0.000006579922,0.0000143420775,0.000071736446,0.000032378433,0.0005984877],"genre_scores_gemma":[0.9994659,0.00006626862,0.00008660873,0.000028350185,0.000007366502,0.0000075916764,0.0001642451,0.0000028310644,0.0001707988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998802,0.000019058454,0.00001011877,0.00001934367,0.000042017044,0.00002917764],"domain_scores_gemma":[0.99975306,0.00003180999,0.000109674635,0.000011072478,0.000024767292,0.00006967655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022079784,0.00022216437,0.00029166412,0.00026169882,0.0001594293,0.00032447203,0.00008980496,0.00018050808,0.00073955185],"category_scores_gemma":[0.0003710243,0.00006422883,0.00016297757,0.00023106254,0.00018982525,0.00013070884,0.000107102125,0.0003284709,0.00016055423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013721237,0.0015667712,0.5290159,0.00013459907,0.00020783689,0.0036746426,0.0002978833,0.00062892283,0.38406682,0.00013338869,0.0010807541,0.065471284],"study_design_scores_gemma":[0.00011680495,0.0055536535,0.94214326,0.000013917287,0.00008433806,0.002712399,0.00010954114,0.0007670044,0.04749887,0.00010727675,0.0008829509,0.000010012293],"about_ca_topic_score_codex":0.0006667919,"about_ca_topic_score_gemma":0.0011758277,"teacher_disagreement_score":0.00073955185,"about_ca_system_score_codex":0.00028775336,"about_ca_system_score_gemma":0.00017815932,"threshold_uncertainty_score":0.00247401},"labels":[],"label_agreement":null},{"id":"W2999177463","doi":"10.1212/nxi.0000000000000663","title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":344,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine; Autoimmune encephalitis; Differential diagnosis; Pediatrics; Pediatric hospital; Encephalitis; Autoantibody; Intensive care medicine; Immunology; Antibody; Pathology","score_opus":0.04274760192593441,"score_gpt":0.2845408300582367,"score_spread":0.2417932281323023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999177463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43009222,0.11148984,0.09952709,0.1564374,0.006063964,0.003651079,0.002502903,0.001096691,0.18913877],"genre_scores_gemma":[0.8809084,0.03225653,0.059646577,0.017124621,0.0038689887,0.0006967312,0.0012808526,0.00010980083,0.0041075577],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775785,0.00082735915,0.0005077591,0.00026005102,0.0003972017,0.0002499098],"domain_scores_gemma":[0.99732333,0.0005958555,0.00044627237,0.00008119733,0.0011375063,0.00041581015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024840883,0.0007418271,0.0006816566,0.0020404186,0.0012751428,0.0017650685,0.0012258629,0.0014752735,0.0032815794],"category_scores_gemma":[0.0071182493,0.00030075596,0.00052326766,0.0011079906,0.001190118,0.0019008204,0.0018922726,0.0038280643,0.0013181505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003508568,0.00044069966,0.55410904,0.0015751546,0.00017935863,0.1549082,0.003677511,0.0028600087,0.009598481,0.010107906,0.067472234,0.19472055],"study_design_scores_gemma":[0.00017340783,0.0006377971,0.22515774,0.0059165293,0.0002235032,0.62578535,0.0104628345,0.0076510585,0.0048998767,0.014624226,0.10428113,0.00018662195],"about_ca_topic_score_codex":0.0036393376,"about_ca_topic_score_gemma":0.0045402697,"teacher_disagreement_score":0.0036393376,"about_ca_system_score_codex":0.0017400956,"about_ca_system_score_gemma":0.003363216,"threshold_uncertainty_score":0.013137221},"labels":[],"label_agreement":null},{"id":"W3028214894","doi":"10.1212/nxi.0000000000000745","title":"Oligodendrocyte ARNT2 expression is altered in models of MS","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"OLIG2; Gene knockdown; Viability assay; Molecular biology; Biology; Cell culture; Experimental autoimmune encephalomyelitis; Oligodendrocyte; Cell biology; Cell; Multiple sclerosis; Biochemistry; Immunology; Endocrinology; Myelin; Central nervous system","score_opus":0.05659512577816669,"score_gpt":0.24243029882230593,"score_spread":0.18583517304413924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028214894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958085,0.0018864125,0.0010261585,0.000052181076,0.000023714814,0.000019574398,0.00030167177,0.000076921046,0.00080486084],"genre_scores_gemma":[0.99427634,0.001489783,0.0011483072,0.00005746729,0.000018283517,0.000063643136,0.0006021507,0.000026986596,0.002317095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998228,0.000020972337,0.000015239419,0.00003713607,0.00006031798,0.000043565193],"domain_scores_gemma":[0.9998412,0.0000112742755,0.00007429698,0.00000996254,0.00002012431,0.0000431448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001572045,0.00059341907,0.0003239256,0.0006712001,0.000221089,0.00033556376,0.0001542714,0.0003837104,0.0011542668],"category_scores_gemma":[0.0001610495,0.00013289815,0.0001842982,0.00029528575,0.00032001745,0.00026597455,0.00021009972,0.0004550894,0.00034244146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000524574,0.00006889751,0.0009480784,0.000051857056,0.000013965431,0.0001842329,0.00004155438,0.00005140744,0.99675435,0.000039115133,0.000037381524,0.0012845722],"study_design_scores_gemma":[0.00007702927,0.0026225515,0.05760818,0.00003298045,0.00015029636,0.002953532,0.00029466054,0.0012089864,0.92967343,0.00022203573,0.005136083,0.000020326845],"about_ca_topic_score_codex":0.00049571996,"about_ca_topic_score_gemma":0.0008746814,"teacher_disagreement_score":0.0011542668,"about_ca_system_score_codex":0.0002826877,"about_ca_system_score_gemma":0.00016838248,"threshold_uncertainty_score":0.0038614273},"labels":[],"label_agreement":null},{"id":"W3033743882","doi":"10.1212/nxi.0000000000000765","title":"Serum antibodies to phosphatidylcholine in MS","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; University of California, San Francisco; National Institutes of Health; Deutsche Forschungsgemeinschaft; Banco Santander; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society; American Cancer Society","keywords":"Antibody; Medicine; Lactosylceramide; Immunology; Nephelometry; Multiple sclerosis; Biomarker; Clinically isolated syndrome; Internal medicine; Gastroenterology; Chemistry","score_opus":0.041348762996198586,"score_gpt":0.3008483055213353,"score_spread":0.2594995425251367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033743882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93565434,0.057532195,0.0006785702,0.00060378324,0.0000944366,0.00008610612,0.0003391167,0.0000411087,0.004970222],"genre_scores_gemma":[0.99588996,0.0031235663,0.0003873975,0.00012035922,0.00009752109,0.000014774824,0.0001498409,0.0000022780819,0.00021439395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995716,0.000102423335,0.00008043019,0.00006310474,0.000132995,0.000049472936],"domain_scores_gemma":[0.99833125,0.00039514725,0.00076893077,0.00003731117,0.00033095782,0.00013636722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007010274,0.00038970006,0.00035490346,0.0018242474,0.00021408996,0.00053756556,0.0002653813,0.0007175968,0.0015227672],"category_scores_gemma":[0.0026012447,0.00009916038,0.00021942532,0.00084459205,0.00027089907,0.00026886477,0.00023288124,0.0002934576,0.000302028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013876414,0.000107998996,0.94417155,0.00049291895,0.00024359196,0.0006333793,0.000036988702,0.00014535653,0.00552856,0.000060483642,0.00064011343,0.046551485],"study_design_scores_gemma":[0.000103187405,0.0010587436,0.9860976,0.00047711984,0.00023892171,0.0052962806,0.000059549897,0.0006290865,0.0036001676,0.00013272795,0.0022959693,0.000010627571],"about_ca_topic_score_codex":0.0007798147,"about_ca_topic_score_gemma":0.0007125332,"teacher_disagreement_score":0.0018242474,"about_ca_system_score_codex":0.0003521068,"about_ca_system_score_gemma":0.0002518251,"threshold_uncertainty_score":0.00509423},"labels":[],"label_agreement":null},{"id":"W3048577711","doi":"10.1212/nxi.0000000000000870","title":"Interleukin-26, preferentially produced by T <sub>H</sub> 17 lymphocytes, regulates CNS barrier function","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Vlaamse regering; Centre de recherche du CHU Sainte-Justine; Multiple Sclerosis Society; Fonds de Recherche du Québec - Santé; Fonds Wetenschappelijk Onderzoek; Multiple Sclerosis Society of Canada","keywords":"Function (biology); Chemistry; Cell biology; Biology","score_opus":0.012176076734275058,"score_gpt":0.19114320554901484,"score_spread":0.17896712881473978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048577711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943895,0.0022889008,0.0014409858,0.00009476818,0.000030202875,0.000032380773,0.00040732996,0.00006710745,0.0012487766],"genre_scores_gemma":[0.9951828,0.0016777964,0.0013875139,0.000087132714,0.000048139675,0.000039536164,0.0002862756,0.000014909932,0.0012757655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999088,0.000019537074,0.000008305307,0.000019658783,0.000011812252,0.000031886968],"domain_scores_gemma":[0.9998927,0.000009981865,0.000043495005,0.00000663189,0.000013252785,0.000033894365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112269525,0.0003720914,0.00017448759,0.00022984635,0.00013948303,0.00029031772,0.00008591262,0.00015954197,0.0018487728],"category_scores_gemma":[0.00011676547,0.00009214543,0.00018772313,0.00011727789,0.00025612948,0.00015350223,0.00011987934,0.00027416516,0.00054452044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005754634,0.00003906441,0.0037564635,0.00008391072,0.000008026522,0.00022000834,0.000031018586,0.00006143731,0.99256283,0.000056185836,0.00013356173,0.0024718998],"study_design_scores_gemma":[0.000119606004,0.0017436985,0.116755724,0.000053175456,0.00006936168,0.0018492347,0.00042811234,0.0011724827,0.8725597,0.0003001949,0.0049313162,0.000017296916],"about_ca_topic_score_codex":0.00025267602,"about_ca_topic_score_gemma":0.00038166178,"teacher_disagreement_score":0.0018487728,"about_ca_system_score_codex":0.00016310443,"about_ca_system_score_gemma":0.00014650894,"threshold_uncertainty_score":0.0061848164},"labels":[],"label_agreement":null},{"id":"W3092849879","doi":"10.1212/nxi.0000000000000899","title":"Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency)","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto Western Hospital","funders":"Hospital for Sick Children","keywords":"Choreoathetosis; CD40; Immunology; Medicine; Immune system; Biology; Genetics; Dystonia","score_opus":0.009183558152803077,"score_gpt":0.19583855613512058,"score_spread":0.1866549979823175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092849879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459444,0.009510342,0.0042837085,0.0016671808,0.00032522588,0.00022515195,0.0008891694,0.00071649766,0.036438357],"genre_scores_gemma":[0.9952114,0.0020507213,0.0007616957,0.00023024273,0.0001455729,0.000016378139,0.0001307169,0.000023985916,0.0014294017],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996351,0.000038858892,0.000028169388,0.00008725441,0.00008589151,0.00012474088],"domain_scores_gemma":[0.9994142,0.00012384314,0.00020527933,0.000036209047,0.000032244578,0.0001882438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012450642,0.0012087345,0.0005360071,0.0014903601,0.0009140317,0.00047533432,0.00035164907,0.0010874718,0.002417778],"category_scores_gemma":[0.0010841066,0.0003762383,0.00030228065,0.001223754,0.001181973,0.00060126773,0.00081147655,0.0012709547,0.00048591694],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009564198,0.00003766998,0.016729468,0.00012228002,0.000016038668,0.96966076,0.00019751894,0.00016390721,0.0071370346,0.00077178027,0.0009201993,0.0041475967],"study_design_scores_gemma":[0.000020459152,0.00007067154,0.021412468,0.00002370297,0.000018332716,0.97433686,0.00007871456,0.000120201206,0.001932668,0.00017202961,0.0018030533,0.000010796897],"about_ca_topic_score_codex":0.007357919,"about_ca_topic_score_gemma":0.0057634288,"teacher_disagreement_score":0.007357919,"about_ca_system_score_codex":0.0009996797,"about_ca_system_score_gemma":0.0010619375,"threshold_uncertainty_score":0.0146301985},"labels":[],"label_agreement":null},{"id":"W3105268192","doi":"10.1212/nxi.0000000000000920","title":"Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS","year":2020,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Wellcome Trust","keywords":"Mendelian randomization; Internal medicine; Randomization; Causal inference; Medicine; Genetics; Randomized controlled trial; Gene; Biology; Genetic variants; Genotype","score_opus":0.027475793085858752,"score_gpt":0.2815630983281582,"score_spread":0.25408730524229944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105268192","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35093594,0.042414293,0.57234424,0.00871144,0.004367827,0.0032611531,0.004802049,0.0033141833,0.009848825],"genre_scores_gemma":[0.93555206,0.0017968883,0.0561743,0.0030289819,0.0004958024,0.00084362394,0.0009812722,0.00023915866,0.00088791474],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.8334111,0.13284229,0.007952448,0.017557982,0.0069560516,0.0012801569],"domain_scores_gemma":[0.7630066,0.18430711,0.01480591,0.033547655,0.0035695906,0.00076313823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12972093,0.002179465,0.0047010845,0.0016605983,0.0011160738,0.0022273858,0.0026182153,0.0026300137,0.007934199],"category_scores_gemma":[0.2344522,0.0011639716,0.013567604,0.0024707408,0.0029829736,0.0018537155,0.0014482967,0.0027808878,0.0006734854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05087544,0.00041857216,0.24492365,0.009706057,0.4950716,0.004484217,0.0010437673,0.014539801,0.008623309,0.036195792,0.013937086,0.12018067],"study_design_scores_gemma":[0.037336793,0.011056126,0.21756871,0.0036454254,0.39390072,0.0078271385,0.00073087314,0.113894284,0.0101961335,0.16417786,0.038823925,0.00084202044],"about_ca_topic_score_codex":0.0038638592,"about_ca_topic_score_gemma":0.0035586196,"teacher_disagreement_score":0.12972093,"about_ca_system_score_codex":0.0008258593,"about_ca_system_score_gemma":0.0018052841,"threshold_uncertainty_score":0.686038},"labels":[],"label_agreement":null},{"id":"W3112296245","doi":"10.1212/nxi.0000000000000931","title":"Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE","year":2020,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Natural Sciences and Engineering Research Council of Canada","funders":"Canadian Institutes of Health Research","keywords":"Proinflammatory cytokine; Interleukin; Medicine; Immunology; Inflammation; Cancer research; Cytokine","score_opus":0.006909339785048311,"score_gpt":0.18631728064276215,"score_spread":0.17940794085771383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112296245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987379,0.000551766,0.0001023497,0.000043280972,0.000012626485,0.000016227114,0.00008731805,0.000014441326,0.00043412528],"genre_scores_gemma":[0.9987871,0.0002230735,0.0002966584,0.000121354926,0.000037600777,0.000014459264,0.00019728343,0.0000034837456,0.00031900548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980503,0.000055195407,0.000036060555,0.000036013884,0.000032022584,0.000035581823],"domain_scores_gemma":[0.99975747,0.00005245129,0.00005822363,0.000016939422,0.000024512141,0.00009036698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030490354,0.0003589867,0.0004571224,0.00038612488,0.00019260305,0.00034767212,0.000089491565,0.00036345335,0.0018616361],"category_scores_gemma":[0.00033878657,0.0001628185,0.00021388226,0.00018002646,0.00018338232,0.00018857706,0.00020221232,0.000452176,0.000396551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117398305,0.0009771172,0.123201,0.0002883975,0.0001109648,0.0015703525,0.00034913814,0.00021516545,0.84148085,0.00006116609,0.00040404557,0.019601982],"study_design_scores_gemma":[0.00089942524,0.019239953,0.7862008,0.00008629868,0.0002978283,0.012756424,0.000561594,0.0012840765,0.17412074,0.00019697624,0.0043245307,0.000031388925],"about_ca_topic_score_codex":0.00020716147,"about_ca_topic_score_gemma":0.00042614207,"teacher_disagreement_score":0.0018616361,"about_ca_system_score_codex":0.00013833835,"about_ca_system_score_gemma":0.00013094499,"threshold_uncertainty_score":0.0062277913},"labels":[],"label_agreement":null},{"id":"W3121035814","doi":"10.1212/nxi.0000000000000941","title":"CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"European Regional Development Fund; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovación; Lundbeckfonden; Generalitat de Catalunya; Red Española de Esclerosis Múltiple; Ministerio de Ciencia, Innovación y Universidades","keywords":"Medicine; Internal medicine","score_opus":0.02142667859796603,"score_gpt":0.265089800017641,"score_spread":0.24366312141967494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121035814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990897,0.00027315502,0.00009376067,0.00004036964,0.0000062038753,0.0000075711805,0.00013909997,0.000015422864,0.00033474198],"genre_scores_gemma":[0.9993228,0.00009280236,0.00018149108,0.00004702143,0.000020014526,0.000008462601,0.00018621152,0.0000018852712,0.00013922586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998853,0.000019138035,0.00001706971,0.000032346186,0.000028902561,0.0000172388],"domain_scores_gemma":[0.9997098,0.000056002948,0.0001156088,0.000009171747,0.000038795362,0.00007060368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015236129,0.00043314774,0.00041412975,0.00069393765,0.0003143897,0.0003269606,0.00014024068,0.0004621183,0.0014006837],"category_scores_gemma":[0.0006691588,0.00014154424,0.00024345373,0.00037701006,0.00023747672,0.00019206553,0.00018574891,0.00028004913,0.0002174001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00257495,0.00010033667,0.9538204,0.000067247885,0.00010520056,0.0015520881,0.00019565297,0.00013926142,0.03309524,0.0000319672,0.0004130733,0.007904552],"study_design_scores_gemma":[0.000039582228,0.0003128378,0.99470264,0.000009612081,0.00004830703,0.0025541566,0.00011722202,0.00023863424,0.0016413061,0.000045724617,0.00028463596,0.0000053008034],"about_ca_topic_score_codex":0.0011743087,"about_ca_topic_score_gemma":0.0013606981,"teacher_disagreement_score":0.0014006837,"about_ca_system_score_codex":0.00022355637,"about_ca_system_score_gemma":0.00016305747,"threshold_uncertainty_score":0.0046857595},"labels":[],"label_agreement":null},{"id":"W3193427671","doi":"10.1212/nxi.0000000000001057","title":"COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; University of British Columbia","funders":"Janssen Pharmaceuticals; Teva Pharmaceutical Industries; National Center for Advancing Translational Sciences; National Cancer Institute; Sanofi Genzyme; Greenwich Biosciences; EMD Serono; Genentech; National Heart, Lung, and Blood Institute; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; BioDelivery Sciences International; MedDay Pharmaceuticals; Horizon Pharmaceuticals; Sanofi; GW Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; AveXis; Pfizer; Biogen; Celgene; U.S. Department of Defense; TG Therapeutics","keywords":"Medicine; Neuromyelitis optica; Internal medicine; Multiple sclerosis; Comorbidity; Rituximab; Pediatrics; Immunology; Lymphoma","score_opus":0.009756802565880364,"score_gpt":0.2588710660790786,"score_spread":0.24911426351319826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193427671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973188,0.0010309238,0.00003970704,0.00030737277,0.000023889785,0.000006978889,0.0004464632,0.0000037685927,0.00082209066],"genre_scores_gemma":[0.99888927,0.00037621395,0.00004749415,0.00010806861,0.000040384522,0.000007812213,0.00042753032,0.0000015170916,0.0001017664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936134,0.0001792394,0.00006989558,0.00013794721,0.0001062554,0.00014525831],"domain_scores_gemma":[0.9980326,0.00029051478,0.001080889,0.000047622525,0.0001412739,0.000407117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006370228,0.00032357158,0.00034062364,0.0006986174,0.0006415133,0.0006836574,0.00044083354,0.0005969247,0.0017785439],"category_scores_gemma":[0.0017769726,0.00025466044,0.00041893206,0.001458825,0.00050630956,0.00078065455,0.0008038074,0.00068253634,0.00018144128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023189974,0.000014390444,0.9991447,0.000006825354,0.000017796945,0.00010097369,0.000064966356,0.000018627947,0.00002328609,0.000012973733,0.00012357264,0.00044872018],"study_design_scores_gemma":[0.0000053058916,0.000034925666,0.9985292,0.000019501562,0.000016997808,0.0005290539,0.00049850636,0.00011637527,0.000010315111,0.0000304639,0.00020654376,0.0000028673712],"about_ca_topic_score_codex":0.026580371,"about_ca_topic_score_gemma":0.027991882,"teacher_disagreement_score":0.026580371,"about_ca_system_score_codex":0.00078593515,"about_ca_system_score_gemma":0.0010386641,"threshold_uncertainty_score":0.05285132},"labels":[],"label_agreement":null},{"id":"W3208942552","doi":"10.1212/nxi.0000000000001098","title":"Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Instituto de Salud Carlos III; Fondazione Regionale per la Ricerca Biomedica; Universitat Autònoma de Barcelona; Grifols; GBS/CIDP Foundation International; Fondazione Cariplo; Sanofi; European Commission; Sarepta Therapeutics; Ministero della Salute; CSL Behring; Teva Pharmaceutical Industries; Medical Research Council; Biogen; Celgene","keywords":"Medicine; Rituximab; Internal medicine; Gastroenterology; Autoantibody; Modified Rankin Scale; Titer; Antibody; Immunology","score_opus":0.0106185965670401,"score_gpt":0.26963807514687216,"score_spread":0.25901947857983204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208942552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962525,0.0012367007,0.00013891517,0.000050894458,0.000010009506,0.000022449916,0.00012840987,0.000009143524,0.002151041],"genre_scores_gemma":[0.9993087,0.00017005295,0.00014081264,0.000048457972,0.000023207012,0.000012235537,0.00013584827,0.0000012630045,0.00015938398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996586,0.00008513948,0.000056854402,0.00007571046,0.000066716064,0.00005696072],"domain_scores_gemma":[0.9989028,0.00024555819,0.00048737138,0.000041892705,0.00012310545,0.00019917318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047739717,0.00030523541,0.00032850314,0.00071511284,0.00026484038,0.00034300575,0.00027249812,0.00051768334,0.0021443774],"category_scores_gemma":[0.0016659304,0.0001394579,0.00014167264,0.00042106683,0.00037188444,0.00038811902,0.00020295173,0.00023801396,0.0003777636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008080294,0.00016215941,0.98129165,0.00007010834,0.000030448315,0.007267242,0.00006654539,0.00007566896,0.0046945815,0.000051624538,0.00021293572,0.0052689156],"study_design_scores_gemma":[0.00005156568,0.00062828517,0.955619,0.000029975135,0.000038582366,0.04191705,0.00013569626,0.0001611662,0.00072859664,0.00005349494,0.0006295222,0.0000070666915],"about_ca_topic_score_codex":0.0005472075,"about_ca_topic_score_gemma":0.000662531,"teacher_disagreement_score":0.0021443774,"about_ca_system_score_codex":0.00028884757,"about_ca_system_score_gemma":0.00023339738,"threshold_uncertainty_score":0.007173598},"labels":[],"label_agreement":null},{"id":"W3211591349","doi":"10.1212/nxi.0000000000001111","title":"Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk Fonden; Lundbeckfonden; Steno Diabetes Center Aarhus; Ipsen; Alnylam Pharmaceuticals","keywords":"Pathogenesis; Innate immune system; Immune system; Diabetic neuropathy; Neuropathic pain; Macrophage; Diabetes mellitus","score_opus":0.004309567778639061,"score_gpt":0.204119199245915,"score_spread":0.19980963146727596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211591349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993789,0.0003201234,0.00004228126,0.0000069182993,0.0000020534665,0.0000052398113,0.000032570882,9.411574e-7,0.0002110041],"genre_scores_gemma":[0.9996007,0.00012255095,0.00007739481,0.000013547022,0.000004072786,0.0000053311387,0.00004221034,4.479849e-7,0.00013373658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997948,0.000055112734,0.00002902736,0.000051763203,0.000041013333,0.00002822609],"domain_scores_gemma":[0.9997154,0.00007126147,0.00009828353,0.000011658126,0.00005221168,0.00005111151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003217723,0.00018237112,0.00019805614,0.00073200266,0.00027526755,0.00030979485,0.00010549182,0.00027644186,0.0012028253],"category_scores_gemma":[0.0007526873,0.0001399133,0.00010209053,0.00031644234,0.00019217636,0.00019895821,0.0001887305,0.0001644424,0.0001630573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006082356,0.00007290339,0.9849881,0.000051465347,0.000033574554,0.0012298372,0.0002964257,0.00003212824,0.009336375,0.0000117916,0.00004603703,0.0032931068],"study_design_scores_gemma":[0.000016516722,0.0003185733,0.9943889,0.000013320159,0.000026659343,0.0037291532,0.00037448466,0.000077819386,0.0008650124,0.000017259494,0.00016952911,0.0000028156867],"about_ca_topic_score_codex":0.0006658768,"about_ca_topic_score_gemma":0.00075162394,"teacher_disagreement_score":0.0012028253,"about_ca_system_score_codex":0.000118040916,"about_ca_system_score_gemma":0.00008641893,"threshold_uncertainty_score":0.00402385},"labels":[],"label_agreement":null},{"id":"W3215557511","doi":"10.1212/nxi.0000000000001092","title":"COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Novartis Pharma","keywords":"Fingolimod; Coronavirus disease 2019 (COVID-19); Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Coronavirus Infections; Multiple sclerosis; Internal medicine; Immunology; Infectious disease (medical specialty)","score_opus":0.015387191711300739,"score_gpt":0.2591846777916339,"score_spread":0.24379748608033316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215557511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625564,0.0012373375,0.00012232596,0.00004698623,0.0000066504526,0.000036345627,0.0008038523,0.000005498742,0.0014852836],"genre_scores_gemma":[0.99805415,0.0005902792,0.00018785859,0.00007545807,0.000022698041,0.000026704482,0.00087493425,0.0000033642007,0.00016449134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993469,0.00011766751,0.00015546441,0.00012936712,0.0001325137,0.000118151715],"domain_scores_gemma":[0.9977108,0.00038390537,0.001514592,0.00006798062,0.00011729665,0.0002054725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055267906,0.00016240127,0.00027682906,0.0015456966,0.00044589458,0.00065741676,0.00020044301,0.00029664213,0.0019955481],"category_scores_gemma":[0.0014472468,0.00013240334,0.00033780534,0.0011266185,0.00030644957,0.00044034133,0.00038505078,0.0003192827,0.0002657064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019742567,0.000024562421,0.99559927,0.00003625945,0.000017569984,0.0008330315,0.000104592524,0.000017634275,0.00044096832,0.00002740298,0.00014424989,0.0025570989],"study_design_scores_gemma":[0.000013429089,0.00023597924,0.9848636,0.000048265003,0.000032737687,0.01236992,0.0005059435,0.000091237984,0.00046192142,0.000029440902,0.0013393317,0.000008227048],"about_ca_topic_score_codex":0.0012162536,"about_ca_topic_score_gemma":0.0012226204,"teacher_disagreement_score":0.0019955481,"about_ca_system_score_codex":0.00037463382,"about_ca_system_score_gemma":0.00046937543,"threshold_uncertainty_score":0.00667572},"labels":[],"label_agreement":null},{"id":"W4200202893","doi":"10.1212/nxi.0000000000001119","title":"Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8 <sup>+</sup> T-Cell Behaviors","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Canadian Institutes of Health Research; Fonds de Recherche du Québec - Santé; University of Washington","keywords":"NKG2D; Downregulation and upregulation; Multiple sclerosis; Immune system; CD8; Signal transduction; Cytotoxic T cell","score_opus":0.018137619926697414,"score_gpt":0.21141883757537383,"score_spread":0.19328121764867642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200202893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881244,0.0005271599,0.00019492395,0.000020957616,0.0000058396736,0.0000043710406,0.00012129437,0.000013556416,0.00029949268],"genre_scores_gemma":[0.9986935,0.00020162523,0.00022577056,0.0000203349,0.000009229794,0.000015745272,0.00020373109,0.0000040679884,0.0006258622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998925,0.000017167262,0.000011469371,0.000024107563,0.000019869962,0.00003484518],"domain_scores_gemma":[0.9999218,0.00000855609,0.000028434806,0.0000064668952,0.000011495079,0.000023239063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072916264,0.00022860648,0.00023281177,0.00034618218,0.00018304377,0.00023924552,0.00008518413,0.00024041354,0.002479585],"category_scores_gemma":[0.00013481641,0.00011728045,0.00011511446,0.00017702747,0.00022230421,0.00011528373,0.00019478712,0.00022166711,0.00038614622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083544315,0.000028998593,0.008466772,0.000060875405,0.000015317617,0.00026509984,0.000042502747,0.000028223241,0.988181,0.000018041475,0.00006315099,0.001994557],"study_design_scores_gemma":[0.00009991803,0.0012616117,0.44464338,0.000030950563,0.00013453135,0.0054776054,0.0007083976,0.00070746685,0.5436731,0.00017631678,0.0030737806,0.000012920152],"about_ca_topic_score_codex":0.0003715239,"about_ca_topic_score_gemma":0.00033037848,"teacher_disagreement_score":0.002479585,"about_ca_system_score_codex":0.00018135842,"about_ca_system_score_gemma":0.00009122767,"threshold_uncertainty_score":0.008295059},"labels":[],"label_agreement":null},{"id":"W4200326784","doi":"10.1212/nxi.0000000000001126","title":"Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders","year":2021,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Outcome (game theory); Psychology; Psychotherapist; Economics","score_opus":0.11840327690146815,"score_gpt":0.3913749760219827,"score_spread":0.27297169912051455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200326784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00421983,0.9748147,0.006327397,0.0065269875,0.00146765,0.00023295014,0.00047737773,0.00009590353,0.005837144],"genre_scores_gemma":[0.06709432,0.9018359,0.01837582,0.0057371287,0.003089692,0.0008983279,0.0008522306,0.00007133822,0.0020451574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962029,0.0018185817,0.00068898546,0.00034232796,0.0008314814,0.00011565657],"domain_scores_gemma":[0.98738146,0.0077552754,0.0015738325,0.00029957958,0.002750087,0.00023985734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008251142,0.0008263749,0.0020026146,0.0019805771,0.00024489878,0.0020575046,0.0008909523,0.0010860551,0.0034310613],"category_scores_gemma":[0.016786749,0.00015965963,0.0015710106,0.0010339814,0.00070226076,0.0014946908,0.0010228169,0.002385005,0.0007234907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004753241,0.00016930111,0.0029025949,0.01281061,0.0006504033,0.00006487818,0.00009341041,0.00048144563,0.00094885717,0.005354319,0.0132014025,0.9628474],"study_design_scores_gemma":[0.0009066013,0.005384421,0.059172336,0.081905864,0.007125992,0.0024794997,0.00077939895,0.004468996,0.0070812395,0.03493371,0.79534644,0.0004155835],"about_ca_topic_score_codex":0.0018388717,"about_ca_topic_score_gemma":0.002545398,"teacher_disagreement_score":0.008251142,"about_ca_system_score_codex":0.0014032016,"about_ca_system_score_gemma":0.0016716302,"threshold_uncertainty_score":0.04363674},"labels":[],"label_agreement":null},{"id":"W4205282783","doi":"10.1212/nxi.0000000000001134","title":"Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Medicine; Neuromyelitis optica; Immunology; Experimental autoimmune encephalomyelitis; Optic neuritis; Antibody; Encephalomyelitis; Pathology; Immunoglobulin G; Luxol fast blue stain; Myelin; Central nervous system; Internal medicine","score_opus":0.025467683437563008,"score_gpt":0.30494597273452806,"score_spread":0.27947828929696505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205282783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931646,0.0029813976,0.00085211365,0.00017089496,0.00014450774,0.000061578125,0.0002144644,0.00022053256,0.0021898441],"genre_scores_gemma":[0.9905591,0.002584153,0.0012308316,0.0002539238,0.00010710343,0.00009030089,0.00060173817,0.000025879732,0.0045470684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997857,0.000034108834,0.000019439482,0.000028685832,0.00005450856,0.00007761797],"domain_scores_gemma":[0.9997509,0.000027073176,0.00006325755,0.000020348567,0.00003911512,0.00009933527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026807922,0.00075234595,0.0006696347,0.00056628167,0.00021263276,0.00031564146,0.00056053227,0.0007234073,0.0018950126],"category_scores_gemma":[0.00020279756,0.0001534222,0.00030442196,0.00014487522,0.00037917268,0.0004267939,0.00015646574,0.0013127495,0.0004924329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040446385,0.0028078433,0.0004790617,0.0002833757,0.000058660415,0.00023238779,0.000060825012,0.00020345216,0.97722876,0.00013614187,0.0005444917,0.013920427],"study_design_scores_gemma":[0.0016798407,0.03149469,0.020796478,0.00014082139,0.00027890108,0.0010452017,0.00016001881,0.0022349972,0.93220115,0.00026409602,0.0096695945,0.00003422658],"about_ca_topic_score_codex":0.00058618933,"about_ca_topic_score_gemma":0.0015013474,"teacher_disagreement_score":0.0018950126,"about_ca_system_score_codex":0.00026387407,"about_ca_system_score_gemma":0.00036822318,"threshold_uncertainty_score":0.006339431},"labels":[],"label_agreement":null},{"id":"W4220654663","doi":"10.1212/nxi.0000000000001153","title":"Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children","year":2022,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UCB Pharma; National Cancer Institute; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Epilepsy Society; Ontario Institute for Regenerative Medicine; Action Medical Research; Sparks; Ono Pharmaceutical; National Multiple Sclerosis Society; Genentech; University of Oxford; National Institutes of Health; Epilepsy Research UK; Great Ormond Street Hospital Charity; CSL Behring; National Institute for Health and Care Research; Multiple Sclerosis Society; Petre Foundation; Wellcome Trust; Cerebral Palsy Alliance; Pfizer; Biogen; Hospital for Sick Children; Sanofi; Sarepta Therapeutics","keywords":"Irritability; Medicine; Context (archaeology); Pediatrics; Ataxia; Regimen; Intensive care medicine; Psychiatry; Cognition; Surgery","score_opus":0.0322765953042198,"score_gpt":0.2892690124645949,"score_spread":0.25699241716037513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220654663","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62264776,0.30226457,0.010721831,0.0276097,0.0016856077,0.00063022727,0.0006187188,0.0004139591,0.03340765],"genre_scores_gemma":[0.90536034,0.07679063,0.012536191,0.0025008298,0.0009577686,0.00018443489,0.00056024425,0.0000383969,0.0010711978],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992299,0.00020624549,0.00016047408,0.00008372925,0.00019030382,0.00012936025],"domain_scores_gemma":[0.99892694,0.00034198607,0.0003710518,0.000019285957,0.00015535552,0.00018536788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009179115,0.0004681629,0.0006208651,0.0017986549,0.00090552063,0.00075808686,0.00061013305,0.0012069019,0.00062877504],"category_scores_gemma":[0.004542516,0.00023566147,0.00037711428,0.00077371515,0.0008263502,0.0008395111,0.0008817964,0.0017686329,0.00021959443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036870295,0.00022697383,0.59652245,0.001753239,0.00010315055,0.12354062,0.0023726223,0.0016094027,0.0041688276,0.0015424282,0.022727065,0.24506451],"study_design_scores_gemma":[0.00012441486,0.00097159547,0.3780827,0.0055836136,0.0002907895,0.53562254,0.0056079915,0.0015420992,0.0049263826,0.0018025785,0.065333694,0.00011159062],"about_ca_topic_score_codex":0.0036548667,"about_ca_topic_score_gemma":0.005533228,"teacher_disagreement_score":0.0036548667,"about_ca_system_score_codex":0.0012695041,"about_ca_system_score_gemma":0.0021838653,"threshold_uncertainty_score":0.009210944},"labels":[],"label_agreement":null},{"id":"W4220836929","doi":"10.1212/nxi.0000000000001156","title":"Cryptococcal Meningitis Reported With Fingolimod Treatment","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of Allergy and Infectious Diseases; U.S. Department of Veterans Affairs","keywords":"Fingolimod; Medicine; Headaches; Pediatrics; Adverse effect; Incidence (geometry); Internal medicine; Multiple sclerosis; Surgery; Psychiatry","score_opus":0.021549688483744136,"score_gpt":0.24719200173713005,"score_spread":0.2256423132533859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220836929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756142,0.016731013,0.00022687469,0.00039152385,0.000043047236,0.00006408089,0.0027638443,0.000022108854,0.004143286],"genre_scores_gemma":[0.99501026,0.0032553547,0.00014732513,0.00015713487,0.00007001411,0.000021411355,0.0012399101,0.0000030505491,0.000095585114],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9983188,0.00027356265,0.00046287512,0.0002978417,0.0004620272,0.00018505637],"domain_scores_gemma":[0.9890013,0.0013123439,0.008704924,0.00021841256,0.0004139141,0.00034907885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007838749,0.00023144664,0.00054228626,0.0017276872,0.00041120002,0.00095933775,0.00029024246,0.0004951405,0.0018410163],"category_scores_gemma":[0.005748009,0.00014835446,0.0005843271,0.0030709638,0.00030210867,0.0006494323,0.00046420042,0.0005478825,0.00027841347],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034166375,0.000037731166,0.98888355,0.000267174,0.00015155728,0.0016563744,0.00016100635,0.000078200486,0.00023514406,0.000056843415,0.00054093945,0.0075897514],"study_design_scores_gemma":[0.00005041354,0.00029323134,0.9623829,0.00047484995,0.00019336767,0.03103409,0.00048995373,0.00022439215,0.0004233951,0.0001079969,0.004304654,0.000020726546],"about_ca_topic_score_codex":0.0029666047,"about_ca_topic_score_gemma":0.0015317694,"teacher_disagreement_score":0.0029666047,"about_ca_system_score_codex":0.00064910896,"about_ca_system_score_gemma":0.00069160876,"threshold_uncertainty_score":0.006158769},"labels":[],"label_agreement":null},{"id":"W4224311696","doi":"10.1212/nxi.0000000000001173","title":"Programmed Cell Death Protein 1–Positive CD8 <sup>+</sup> T Cells in Multiple Sclerosis","year":2022,"lang":"en","type":"letter","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Multiple sclerosis; Programmed cell death; CD8; Cytotoxic T cell; Cell; Cell biology; Chemistry; Biology; Immunology; Apoptosis; Biochemistry; Immune system; In vitro","score_opus":0.036903279635318836,"score_gpt":0.24930107587053896,"score_spread":0.21239779623522012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224311696","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011486059,0.005308462,0.00044314066,0.9445149,0.02186089,0.00003699711,0.00007930677,0.000083871426,0.01618638],"genre_scores_gemma":[0.16108869,0.0053245514,0.0011661786,0.66434604,0.14076024,0.00013222646,0.00011249485,0.000067532674,0.02700202],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9993272,0.00022605907,0.00008952392,0.0000678691,0.00016366321,0.00012571887],"domain_scores_gemma":[0.99745816,0.0016157216,0.00015502682,0.000110698995,0.0003777587,0.0002825806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096845283,0.0006572743,0.0010466464,0.0004982924,0.0021946607,0.0014621259,0.0009565208,0.024707826,0.0029960333],"category_scores_gemma":[0.005809039,0.0004048823,0.0005794698,0.00035285985,0.0016149968,0.0013560059,0.0005426717,0.0108115,0.0018780313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006182341,0.00012589149,0.004450186,0.00023853716,0.00004890879,0.11491483,0.00024422837,0.00026906095,0.0027600257,0.005684034,0.84034914,0.030296877],"study_design_scores_gemma":[0.0014889402,0.0007243637,0.010441368,0.0007799257,0.00022363495,0.18450049,0.0008647658,0.006027865,0.00418817,0.040198553,0.75044054,0.000121361736],"about_ca_topic_score_codex":0.0023100872,"about_ca_topic_score_gemma":0.0029791286,"teacher_disagreement_score":0.024707826,"about_ca_system_score_codex":0.002743846,"about_ca_system_score_gemma":0.0011289787,"threshold_uncertainty_score":0.01990807},"labels":[],"label_agreement":null},{"id":"W4233752323","doi":"10.1212/nxi.0000000000000276","title":"Restoring immune tolerance in neuromyelitis optica","year":2016,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Guthy-Jackson Charitable Foundation","keywords":"Neuromyelitis optica; Medicine; Immune system; Immune tolerance; Immunology; Disease; Neuroscience; Bioinformatics; Multiple sclerosis; Psychology; Internal medicine; Biology","score_opus":0.060791888819849545,"score_gpt":0.3480146735541715,"score_spread":0.28722278473432195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233752323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056432888,0.999466,0.000025393734,0.00010347712,0.000056799014,0.0000020873867,0.000005454975,0.0000021466328,0.00028215637],"genre_scores_gemma":[0.0004694852,0.9991092,0.000080894344,0.000078443554,0.000067798785,0.0000036692456,0.000009285207,5.762014e-7,0.00018062616],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998354,0.000036367644,0.000038114926,0.000024914676,0.000052734613,0.00001255184],"domain_scores_gemma":[0.99970776,0.00015973575,0.000050741917,0.0000075308567,0.00005498069,0.000019206522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005806888,0.00062568113,0.0011781881,0.0033442164,0.0002757843,0.0008216935,0.0006240437,0.00089783245,0.0025822131],"category_scores_gemma":[0.000776006,0.00020109695,0.0005200112,0.0026849755,0.00042095504,0.001090727,0.0006227766,0.0010170122,0.0012392446],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007213265,0.00006574954,0.00015901004,0.03269224,0.00009615454,0.00018574616,0.00006862614,0.00017021877,0.0007611584,0.0022795142,0.014951644,0.94849795],"study_design_scores_gemma":[0.000032569642,0.00013863956,0.0016306728,0.015447517,0.00028705728,0.0024790564,0.00013078186,0.00007984219,0.0005075526,0.0023178556,0.9769233,0.000025093384],"about_ca_topic_score_codex":0.0011116079,"about_ca_topic_score_gemma":0.0021303713,"teacher_disagreement_score":0.0033442164,"about_ca_system_score_codex":0.00048483082,"about_ca_system_score_gemma":0.0010624207,"threshold_uncertainty_score":0.008638382},"labels":[],"label_agreement":null},{"id":"W4282921382","doi":"10.1212/nxi.0000000000200005","title":"Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Saskatchewan Health Quality Council; University of Saskatchewan; Nova Scotia Health Authority; Dalhousie University","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Department of Health, Western Cape Government; Dalhousie University; Research Nova Scotia; European Committee for Treatment and Research in Multiple Sclerosis; Research Manitoba; Multiple Sclerosis Society; Multiple Sclerosis Trust; Nova Scotia Department of Health and Wellness; Ministry of Health, Saskatchewan; Multiple Sclerosis Society of Canada; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Michael Smith Health Research BC; Biogen; U.S. Department of Defense","keywords":"Disease; Multiple sclerosis; Association (psychology); Medicine; Oncology; Internal medicine; Psychology; Psychiatry; Psychotherapist","score_opus":0.04376940209504658,"score_gpt":0.26529876956453924,"score_spread":0.22152936746949264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282921382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002737,0.004729874,0.000108716624,0.0004300121,0.000017990727,0.000017585087,0.0026701728,0.000011210921,0.0019870535],"genre_scores_gemma":[0.9989548,0.00037646655,0.000059438604,0.000034518434,0.0000079894,0.0000040081686,0.00041895988,9.4952725e-7,0.00014294552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929917,0.00015321787,0.00006470112,0.0000905378,0.0002184425,0.00017392286],"domain_scores_gemma":[0.99627054,0.000777627,0.0017234599,0.00017554729,0.00060695474,0.000445786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010449965,0.00015402536,0.00023071164,0.000587999,0.00037250752,0.0004767242,0.0003196266,0.00020801216,0.0015078585],"category_scores_gemma":[0.004751969,0.00007304202,0.0005240429,0.001174311,0.00023430421,0.0001318369,0.00021241006,0.0005324033,0.00006980996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034324254,0.0000185283,0.99617887,0.000046386733,0.00020174879,0.00002269254,0.000038268274,0.00008037206,0.00009243589,0.000035625824,0.000230567,0.0027111724],"study_design_scores_gemma":[0.00000882184,0.000047628244,0.9991468,0.000016219876,0.00009593884,0.000059349986,0.00003527444,0.000099324585,0.000045513763,0.000018779818,0.0004239029,0.000002399069],"about_ca_topic_score_codex":0.23548667,"about_ca_topic_score_gemma":0.31006056,"teacher_disagreement_score":0.23548667,"about_ca_system_score_codex":0.0017951124,"about_ca_system_score_gemma":0.0028025003,"threshold_uncertainty_score":0.46823198},"labels":[],"label_agreement":null},{"id":"W4295037651","doi":"10.1212/nxi.0000000000200022","title":"CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immune system; Peripheral blood mononuclear cell; Flow cytometry; Human brain; Multiple sclerosis; Pathology; Microglia; Biology; Inflammation; Antibody; Immunology; Cell; In vitro; Medicine","score_opus":0.046231315994908165,"score_gpt":0.2436534667323145,"score_spread":0.19742215073740632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295037651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961299,0.0024272515,0.0007538032,0.00006811249,0.00001576882,0.0000096455005,0.000064861066,0.000014909697,0.0005157295],"genre_scores_gemma":[0.9969433,0.00086375384,0.0012019633,0.00003951831,0.000018061683,0.000023997429,0.00011070793,0.0000041405533,0.0007946296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991107,0.000022795724,0.000005357992,0.000014331348,0.000020395368,0.000026088836],"domain_scores_gemma":[0.9998925,0.000018275152,0.000030476876,0.0000067717383,0.000025339456,0.000026604495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121869394,0.00017602196,0.00012264593,0.00032317205,0.00016662513,0.0002561871,0.000100686724,0.00020910866,0.0012551479],"category_scores_gemma":[0.00020891098,0.000059870283,0.000103471866,0.00011988905,0.0001246227,0.00017198545,0.00019887058,0.0004196619,0.00028419937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004318446,0.00004793768,0.002958958,0.00012353255,0.000008902727,0.00035927864,0.00010153431,0.000053586577,0.98954123,0.000110704175,0.00014192471,0.0061206142],"study_design_scores_gemma":[0.00022248898,0.0020713022,0.17135926,0.0001881233,0.000073807416,0.0056595234,0.0011931742,0.003347728,0.80108345,0.0007437151,0.014036241,0.000021101376],"about_ca_topic_score_codex":0.00035595574,"about_ca_topic_score_gemma":0.0003354587,"teacher_disagreement_score":0.0012551479,"about_ca_system_score_codex":0.00019722132,"about_ca_system_score_gemma":0.00011260029,"threshold_uncertainty_score":0.004198909},"labels":[],"label_agreement":null},{"id":"W4304807432","doi":"10.1212/nxi.0000000000200032","title":"Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3","year":2022,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute of Health Services and Policy Research; St. Michael's Hospital; Mount Sinai Hospital","funders":"","keywords":"Term (time); Multiple sclerosis; Association (psychology); Medicine; Internal medicine; Psychology; Psychiatry; Psychotherapist; Physics","score_opus":0.0640300232606055,"score_gpt":0.3304874727833093,"score_spread":0.2664574495227038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304807432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055270877,0.940479,0.0011540677,0.0004632977,0.000604034,0.00044111317,0.0008995087,0.000029066205,0.00065897166],"genre_scores_gemma":[0.7466559,0.24373226,0.0037916664,0.0012317083,0.00072973757,0.0016649499,0.0013167467,0.000040837265,0.00083614746],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.98722875,0.0071292846,0.0030577462,0.0013178146,0.0009641052,0.00030230085],"domain_scores_gemma":[0.9706566,0.022688175,0.004578006,0.0006445036,0.0010945032,0.00033824999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019448785,0.0016668299,0.011475426,0.0032806122,0.0005294906,0.0031092302,0.0018197517,0.0027116784,0.0029410224],"category_scores_gemma":[0.035710458,0.00092109956,0.03833549,0.003515744,0.0008382601,0.0016767444,0.0012879862,0.0020264024,0.00021497502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035645034,0.000091208014,0.017826423,0.14771546,0.78544176,0.00021863772,0.00011027238,0.00072464586,0.00046694867,0.00023965619,0.00044726022,0.011072726],"study_design_scores_gemma":[0.0052424497,0.0012210537,0.014610407,0.0068390733,0.9694631,0.00014310499,0.000051206025,0.00061115687,0.0002467234,0.00038503646,0.0011502265,0.000036550584],"about_ca_topic_score_codex":0.003964785,"about_ca_topic_score_gemma":0.005413127,"teacher_disagreement_score":0.019448785,"about_ca_system_score_codex":0.0014065003,"about_ca_system_score_gemma":0.0017278255,"threshold_uncertainty_score":0.10285622},"labels":[],"label_agreement":null},{"id":"W4309866766","doi":"10.1212/nxi.0000000000200062","title":"Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis","year":2022,"lang":"en","type":"review","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Mental Health; Canadian Institutes of Health Research; Biogen; Amgen","keywords":"Vitamin D and neurology; Expanded Disability Status Scale; Genome-wide association study; Mendelian randomization; Confounding; Multiple sclerosis; Medicine; Internal medicine; Observational study; Oncology; Genetics; Single-nucleotide polymorphism; Biology; Immunology; Genotype","score_opus":0.05437899373133189,"score_gpt":0.2984337808973357,"score_spread":0.2440547871660038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309866766","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002188867,0.9994842,0.00003318537,0.000085733045,0.000025109837,0.0000050748204,0.0000287917,0.0000015768162,0.000117355405],"genre_scores_gemma":[0.0033662901,0.99630004,0.00012961612,0.00006275919,0.000030668547,0.000013271613,0.00004132824,6.637122e-7,0.000055326134],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99926025,0.00028681764,0.00015589394,0.00010737767,0.00016508467,0.000024477928],"domain_scores_gemma":[0.99811757,0.0013849019,0.00028226303,0.0000307112,0.00015452762,0.000030107109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018604313,0.000617301,0.0023835509,0.0026311423,0.00015478948,0.000713859,0.0007352088,0.00075278763,0.0022568023],"category_scores_gemma":[0.004590927,0.00022997502,0.0016058519,0.0026423603,0.00030663455,0.0004529918,0.00045452965,0.0006538928,0.00027009263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004477752,0.000042390722,0.0031511518,0.15055105,0.005282022,0.00009770609,0.000074073854,0.000300109,0.00024030758,0.0013593043,0.0068858895,0.8315683],"study_design_scores_gemma":[0.00093618693,0.0010547744,0.07565336,0.31684983,0.060668528,0.0055460944,0.00047325043,0.0008628721,0.0013646053,0.0071402895,0.52924645,0.00020370404],"about_ca_topic_score_codex":0.0038434782,"about_ca_topic_score_gemma":0.00487894,"teacher_disagreement_score":0.0038434782,"about_ca_system_score_codex":0.0005638513,"about_ca_system_score_gemma":0.001394947,"threshold_uncertainty_score":0.009838998},"labels":[],"label_agreement":null},{"id":"W4310593807","doi":"10.1212/nxi.0000000000200046","title":"Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Neuroinflammation; Experimental autoimmune encephalomyelitis; Immune system; Biology; Multiple sclerosis; Immunology; Microglia; Transcriptome; Cell biology; Pathology; Inflammation; Gene expression; Medicine; Gene","score_opus":0.009087682087432337,"score_gpt":0.2029845000075888,"score_spread":0.19389681792015648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310593807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799554,0.0017698414,0.014773004,0.00009663812,0.000027244989,0.000027157306,0.0023972974,0.00009449678,0.0008589784],"genre_scores_gemma":[0.9863207,0.0012778111,0.009282336,0.0001077703,0.000025440062,0.000094618255,0.0019665682,0.000026277647,0.0008985463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998795,0.000011505658,0.0000061271526,0.000047351325,0.000031455158,0.000024152538],"domain_scores_gemma":[0.99990654,0.000023825629,0.000025139834,0.0000090587255,0.000021231288,0.000014173548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018572572,0.00015447485,0.00025860066,0.0003816785,0.00016496239,0.0003572963,0.00014269231,0.00028217203,0.0005427517],"category_scores_gemma":[0.00016359927,0.0000947065,0.00016648934,0.0003006281,0.00022365464,0.00020898988,0.00015360312,0.00036968142,0.00017409024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008619186,0.000010411144,0.0017455784,0.000051231815,0.000011435321,0.00003116228,0.00002582606,0.00023832243,0.9954391,0.00008958099,0.000052738495,0.0022185438],"study_design_scores_gemma":[0.000023020368,0.00040893166,0.23041579,0.000041790063,0.00015281813,0.00066427677,0.00041999822,0.012922628,0.7485766,0.0015441385,0.00480271,0.00002738932],"about_ca_topic_score_codex":0.00029093065,"about_ca_topic_score_gemma":0.00076040387,"teacher_disagreement_score":0.0005427517,"about_ca_system_score_codex":0.00017776276,"about_ca_system_score_gemma":0.00012897453,"threshold_uncertainty_score":0.0018157363},"labels":[],"label_agreement":null},{"id":"W4311910797","doi":"10.1212/nxi.0000000000200071","title":"Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar","year":2022,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Neuromyelitis optica; Medicine; Expanded Disability Status Scale; Internal medicine; Gastroenterology; Spectrum disorder; Double blind; Placebo; Antibody; Multiple sclerosis; Immunology; Pathology","score_opus":0.015149344954275105,"score_gpt":0.2691153934503412,"score_spread":0.2539660484960661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311910797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98207927,0.0156711,0.0002779999,0.0003751351,0.00014554843,0.0003703054,0.00043693898,0.000019642404,0.0006239877],"genre_scores_gemma":[0.9914961,0.0053311093,0.0006287839,0.0006013827,0.00025539222,0.00030449894,0.00077141635,0.000012295707,0.00059912784],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99903935,0.0004871889,0.00018608417,0.00011617961,0.00010056972,0.00007072199],"domain_scores_gemma":[0.9980692,0.00061284844,0.00046815394,0.00022542877,0.00030309224,0.000321281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003540227,0.0007228774,0.0020137979,0.00040773812,0.0003868118,0.00061014586,0.0005280474,0.00067132385,0.0014676956],"category_scores_gemma":[0.0018164616,0.00038728467,0.0021238138,0.0002867671,0.000622305,0.0005478992,0.00042388818,0.0012685934,0.00027306168],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78399956,0.006872868,0.018841933,0.002733082,0.0064163143,0.00024901293,0.0004525377,0.0005060635,0.04332942,0.00015645655,0.0019375721,0.1345052],"study_design_scores_gemma":[0.45764843,0.35504118,0.15639624,0.0004142222,0.010884875,0.00082766375,0.00020285268,0.0011701566,0.010411345,0.00028867938,0.006604818,0.00010957974],"about_ca_topic_score_codex":0.00090539304,"about_ca_topic_score_gemma":0.0017157112,"teacher_disagreement_score":0.003540227,"about_ca_system_score_codex":0.0005038833,"about_ca_system_score_gemma":0.00084542064,"threshold_uncertainty_score":0.018722773},"labels":[],"label_agreement":null},{"id":"W4321434823","doi":"10.1212/nxi.0000000000200095","title":"Levels of Soluble Interleukin 6 Receptor and Asp358Ala Are Associated With Cognitive Performance and Alzheimer Disease Biomarkers","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Aging; Wake Forest University","keywords":"Neuroinflammation; Interleukin 6; Dementia; Disease; Cognition; Medicine; Alzheimer's disease; Receptor; Cytokine; Montreal Cognitive Assessment; Internal medicine; Immunology; Psychology; Neuroscience","score_opus":0.040308740970839974,"score_gpt":0.24822169708073427,"score_spread":0.2079129561098943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321434823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999153,0.00016201031,0.00013768217,0.000027150038,0.0000059964373,0.000006586483,0.00026550298,0.00000937985,0.00023277859],"genre_scores_gemma":[0.99912626,0.000044935896,0.00024357767,0.000035439138,0.000011689141,0.000008770689,0.00027918487,0.000002963281,0.00024730706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997713,0.000055346085,0.000028820905,0.00007830443,0.000032384352,0.000033747376],"domain_scores_gemma":[0.99922,0.00011489614,0.0004124914,0.00006284086,0.00007331974,0.00011640603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046271272,0.00043845124,0.00026134725,0.0004368946,0.00033167648,0.00038378392,0.00024148132,0.00049831497,0.002198647],"category_scores_gemma":[0.0008569305,0.00019525367,0.00035953557,0.00039702404,0.00022037614,0.00016923914,0.0002356336,0.00040455782,0.00030880346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014503662,0.0001107165,0.98759407,0.000020944251,0.0002239352,0.00017711168,0.000075678276,0.00007104578,0.008212368,0.000028360793,0.00015867606,0.0018767468],"study_design_scores_gemma":[0.00001731242,0.00020666173,0.99820423,0.0000033635451,0.00005120122,0.00049925654,0.000033187633,0.00013772823,0.0006742258,0.00003228226,0.00013678656,0.0000036712331],"about_ca_topic_score_codex":0.0020521132,"about_ca_topic_score_gemma":0.0016423317,"teacher_disagreement_score":0.002198647,"about_ca_system_score_codex":0.00013045334,"about_ca_system_score_gemma":0.000102591745,"threshold_uncertainty_score":0.0073551536},"labels":[],"label_agreement":null},{"id":"W4362593230","doi":"10.1212/nxi.0000000000200115","title":"Prolonged Corticosteroids Without Maintenance Immunotherapy for Treatment of Anti-LGI1 Encephalitis","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Foundation; Academic Medical Organization of Southwestern Ontario; London Health Sciences Centre","keywords":"Medicine; Rituximab; Interquartile range; Autoimmune encephalitis; Regimen; Maintenance therapy; Immunotherapy; Encephalitis; Retrospective cohort study; Surgery; Pediatrics; Internal medicine; Immunology; Chemotherapy; Lymphoma; Cancer","score_opus":0.02988328175396148,"score_gpt":0.295490237983504,"score_spread":0.2656069562295425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362593230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662316,0.0026452444,0.00009719453,0.000050955365,0.000005966112,0.000015527885,0.00014794906,0.000004835935,0.00040924267],"genre_scores_gemma":[0.9987865,0.00076664734,0.00008761342,0.000053187534,0.000025580768,0.000010053357,0.00021473676,0.0000020304494,0.000053645243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995658,0.00008746514,0.00008772393,0.00007307401,0.00010869403,0.00007734267],"domain_scores_gemma":[0.9976802,0.00033733362,0.0016468386,0.00004933432,0.00010969698,0.00017655913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041154452,0.00012308128,0.00024305853,0.0003733695,0.00024236474,0.00032246602,0.0002367788,0.00031351688,0.0007352199],"category_scores_gemma":[0.0019269731,0.00008380323,0.00023142634,0.0005991674,0.0002027558,0.00032411804,0.00018702153,0.00028494332,0.00015311674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036006776,0.00006231947,0.9844594,0.00008545604,0.0000658751,0.00207976,0.0000893398,0.000078341356,0.0007017624,0.000018919813,0.00018039238,0.011818424],"study_design_scores_gemma":[0.000052222713,0.00084917014,0.98194504,0.000114121794,0.00007864403,0.015591961,0.00018433585,0.00018207711,0.00036604225,0.00002093059,0.0006093247,0.000006116214],"about_ca_topic_score_codex":0.0011002048,"about_ca_topic_score_gemma":0.002079645,"teacher_disagreement_score":0.0011002048,"about_ca_system_score_codex":0.0003356911,"about_ca_system_score_gemma":0.00045068358,"threshold_uncertainty_score":0.0024595857},"labels":[],"label_agreement":null},{"id":"W4366815631","doi":"10.1212/nxi.0000000000200118","title":"Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; Deutscher Akademischer Austauschdienst","keywords":"Ocrelizumab; CD8; Repertoire; Biology; Immunology; T-cell receptor; T cell; Antibody; Antigen; Immune system; Rituximab","score_opus":0.0271945788087527,"score_gpt":0.26228726423221144,"score_spread":0.23509268542345874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366815631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973525,0.001546741,0.00010251446,0.00015537924,0.000046516296,0.0000951632,0.00021435526,0.000015928685,0.0004709407],"genre_scores_gemma":[0.99771297,0.00048638665,0.0002504184,0.00029926316,0.00008668807,0.00016561119,0.000634815,0.000009163803,0.0003546672],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951315,0.00024330949,0.000030838106,0.000069499576,0.00004749672,0.00009561261],"domain_scores_gemma":[0.9991265,0.00020662948,0.00021366264,0.00008787709,0.000043881864,0.0003214705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022607367,0.0007829592,0.001679769,0.00019873978,0.00033169452,0.0009114172,0.00037326702,0.0004895892,0.0014129262],"category_scores_gemma":[0.0012372024,0.00026600828,0.001029107,0.00020666728,0.00056795357,0.00053797074,0.00036841995,0.0015551791,0.00017156647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8888775,0.0035734987,0.020650608,0.00039904055,0.0015254652,0.00018028414,0.00015060646,0.0010613494,0.019768152,0.0001555285,0.001665864,0.061992098],"study_design_scores_gemma":[0.61616224,0.23893759,0.12224312,0.00010170758,0.0038964471,0.00093551655,0.00019461251,0.0029053078,0.007824301,0.0008770033,0.0058296015,0.00009258576],"about_ca_topic_score_codex":0.00048691378,"about_ca_topic_score_gemma":0.0011402387,"teacher_disagreement_score":0.0022607367,"about_ca_system_score_codex":0.00046076308,"about_ca_system_score_gemma":0.00084738125,"threshold_uncertainty_score":0.011956036},"labels":[],"label_agreement":null},{"id":"W4381432934","doi":"10.1212/nxi.0000000000200121","title":"Complement Factor I Gene Variant as a Treatable Cause of Recurrent Aseptic Neutrophilic Meningitis","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Aseptic meningitis; Canakinumab; Medicine; Meningitis; Complement factor I; Immunology; Complement system; Inflammation; Complement (music); Monoclonal antibody; Antibody; Gene; Internal medicine; Pediatrics; Genetics; Biology; Anakinra; Disease","score_opus":0.03321239040554943,"score_gpt":0.27375718683264577,"score_spread":0.24054479642709634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381432934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819171,0.0071851597,0.0015269796,0.0016224722,0.00018210891,0.0000801431,0.000068645146,0.00017026039,0.007247078],"genre_scores_gemma":[0.9980782,0.0007357113,0.00023621431,0.0003039538,0.00014696324,0.0000067957903,0.00003084901,0.000007739276,0.0004535336],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99977094,0.000043435823,0.000019943727,0.00003679593,0.000041545172,0.00008738069],"domain_scores_gemma":[0.999671,0.00008010564,0.00007777399,0.000024409086,0.000023310891,0.00012331286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020324763,0.0006723823,0.00068430114,0.0005807786,0.0008294288,0.00039204553,0.0004902,0.0017091556,0.0008345907],"category_scores_gemma":[0.0010783334,0.00019839162,0.0004477619,0.00036178814,0.00061820436,0.00032983406,0.00031633617,0.0011242197,0.00029057806],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014706857,0.00007766765,0.009265368,0.00003186751,0.00001989704,0.98253816,0.00013625743,0.000117672476,0.0029827293,0.00018332066,0.0003945995,0.0041054715],"study_design_scores_gemma":[0.000059321977,0.00034744476,0.014739923,0.00002258165,0.000037368904,0.98172873,0.000080823585,0.00042511927,0.0011586929,0.00012627988,0.0012622323,0.000011418608],"about_ca_topic_score_codex":0.0011501553,"about_ca_topic_score_gemma":0.0011630184,"teacher_disagreement_score":0.0017091556,"about_ca_system_score_codex":0.00044606123,"about_ca_system_score_gemma":0.00034469986,"threshold_uncertainty_score":0.0032364726},"labels":[],"label_agreement":null},{"id":"W4385448740","doi":"10.1212/nxi.0000000000200144","title":"Structural Changes of Cutaneous Immune Cells in Patients With Type 1 Diabetes and Their Relationship With Diabetic Polyneuropathy","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Steno Diabetes Center Aarhus; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen; Lundbeckfonden; Vertex Pharmaceuticals; Alnylam Pharmaceuticals","keywords":"Polyneuropathy; Diabetes mellitus; Medicine; Immune system; Type 2 diabetes; Internal medicine; Type 1 diabetes; Immunology; Endocrinology","score_opus":0.008052098084308157,"score_gpt":0.19376039136145923,"score_spread":0.18570829327715108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385448740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888855,0.00055853673,0.00007841232,0.000032453194,0.0000057949633,0.000005894416,0.00007515825,0.0000027187916,0.00035245842],"genre_scores_gemma":[0.9995565,0.00013544441,0.00011333631,0.000020011115,0.000011811322,0.0000051526426,0.00004929045,6.7033403e-7,0.00010767298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998312,0.000039192124,0.000020817679,0.00004909216,0.000027961736,0.000031664862],"domain_scores_gemma":[0.9992644,0.00014733181,0.00038673397,0.000026659434,0.00007070979,0.00010405469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031047463,0.00019376165,0.00019841318,0.0006250538,0.00028239973,0.00032682097,0.00016493282,0.0003891382,0.002253722],"category_scores_gemma":[0.0010246871,0.000118700336,0.00018640359,0.00064795377,0.00021756144,0.00029469008,0.00021673348,0.00033553704,0.00015677084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004436808,0.000056009703,0.99438727,0.000030681684,0.00003430514,0.00027669294,0.00009361629,0.000026937998,0.0011901805,0.000010824436,0.000047986923,0.00340178],"study_design_scores_gemma":[0.000005766489,0.00012045319,0.9986551,0.0000064223163,0.000015239457,0.000753124,0.00016451771,0.000056544068,0.00012276556,0.000022661749,0.0000752207,0.0000020619564],"about_ca_topic_score_codex":0.001020444,"about_ca_topic_score_gemma":0.0011350699,"teacher_disagreement_score":0.002253722,"about_ca_system_score_codex":0.0001626559,"about_ca_system_score_gemma":0.00010393129,"threshold_uncertainty_score":0.0075393915},"labels":[],"label_agreement":null},{"id":"W4387446403","doi":"10.1212/nxi.0000000000200167","title":"Increasing Neurofilament and Glial Fibrillary Acidic Protein After Treatment Discontinuation Predicts Multiple Sclerosis Disease Activity","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi Genzyme; EMD Serono; National Institutes of Health; Genentech; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; MedDay Pharmaceuticals; Biogen; Celgene; Cure Alzheimer's Fund; U.S. Department of Defense; Sanofi; Verily Life Sciences; Bristol-Myers Squibb","keywords":"Glial fibrillary acidic protein; Multiple sclerosis; Discontinuation; Neurofilament; Disease; Medicine; Chemistry; Pathology; Internal medicine; Immunology; Immunohistochemistry","score_opus":0.04628236456953838,"score_gpt":0.2698799443217441,"score_spread":0.22359757975220573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387446403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991825,0.00019438475,0.00006934763,0.000046237314,0.000005026713,0.0000064665523,0.0002063317,0.000004790608,0.00028489393],"genre_scores_gemma":[0.9996113,0.00003193484,0.000043469252,0.000025232006,0.000010523492,0.0000050562335,0.00016722178,9.878362e-7,0.000104404084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996551,0.000097224765,0.000044542292,0.00006341637,0.00006781003,0.000071839066],"domain_scores_gemma":[0.997195,0.0004656578,0.0017946417,0.00009664129,0.0001596348,0.00028831352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065778784,0.00018229203,0.0002689699,0.00031871584,0.00027291567,0.00034466863,0.00017591189,0.0002894284,0.0020380013],"category_scores_gemma":[0.0019538808,0.00012105668,0.00036069786,0.000347849,0.0001570093,0.00024392098,0.00019822257,0.00040884342,0.00019945927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029503476,0.000029061459,0.9980628,0.000005142357,0.000030569634,0.00002335978,0.000014467613,0.000029649174,0.00022554645,0.0000027364902,0.00008563301,0.0011959305],"study_design_scores_gemma":[0.000012086024,0.00013342556,0.99934775,0.000002466968,0.000017950015,0.000108599044,0.000020919993,0.00017846754,0.000090250294,0.000005703608,0.00008079206,0.0000015496644],"about_ca_topic_score_codex":0.0022013853,"about_ca_topic_score_gemma":0.0025908328,"teacher_disagreement_score":0.0022013853,"about_ca_system_score_codex":0.0002048629,"about_ca_system_score_gemma":0.00019367319,"threshold_uncertainty_score":0.0068178177},"labels":[],"label_agreement":null},{"id":"W4388563357","doi":"10.1212/nxi.0000000000200178","title":"Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Genentech; Epilepsy Society; Eisai; Horizon Therapeutics; EMD Serono; National Football League Players Association; Biogen; Mylan; Cleveland Clinic; Pfizer","keywords":"Interquartile range; Medicine; Autoimmune encephalitis; Modified Rankin Scale; Internal medicine; Montreal Cognitive Assessment; Expanded Disability Status Scale; Retrospective cohort study; Encephalitis; Pediatrics; Cognitive impairment; Disease; Immunology; Multiple sclerosis","score_opus":0.04242497372743751,"score_gpt":0.3452840849990816,"score_spread":0.30285911127164405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388563357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938524,0.000115935,0.000051655723,0.00003803242,0.00000357928,0.000003910833,0.00020670843,0.0000018727089,0.00019298938],"genre_scores_gemma":[0.9996055,0.000034641434,0.00004026794,0.000013019263,0.000007982703,0.0000043682494,0.00024693558,7.138782e-7,0.0000465617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996393,0.00011229344,0.00004918817,0.00006482247,0.000041466756,0.00009286532],"domain_scores_gemma":[0.99773526,0.0003315694,0.0013370775,0.000104218474,0.00014237248,0.0003494599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009874001,0.00020950242,0.00017870817,0.00047699217,0.00033398203,0.00047683236,0.00026013286,0.00034259184,0.0013037036],"category_scores_gemma":[0.0026459594,0.00012387558,0.00037766076,0.000526316,0.0002591743,0.0005099589,0.000476651,0.0004716516,0.00024168608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000703677,0.000010761022,0.9993575,0.000002021429,0.000010179174,0.000035486002,0.00001633422,0.00001766445,0.00005772221,0.0000044536146,0.000024761295,0.00039273078],"study_design_scores_gemma":[0.000003901696,0.000099886696,0.9992912,0.0000036090155,0.0000084700205,0.00024223686,0.00007762975,0.00013420115,0.00004344352,0.00002474202,0.00006860766,0.0000019242557],"about_ca_topic_score_codex":0.0036182902,"about_ca_topic_score_gemma":0.0040918067,"teacher_disagreement_score":0.0036182902,"about_ca_system_score_codex":0.00029530152,"about_ca_system_score_gemma":0.0004224553,"threshold_uncertainty_score":0.0071944594},"labels":[],"label_agreement":null},{"id":"W4389469525","doi":"10.1212/nxi.0000000000200186","title":"Defining the Clinicoradiologic Syndrome of SARS-CoV-2 Acute Necrotizing Encephalopathy","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Encephalopathy; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Pathology; Internal medicine; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.02417815315765875,"score_gpt":0.31242451227251894,"score_spread":0.2882463591148602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389469525","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037621353,0.9582727,0.0005142402,0.000722036,0.00010817564,0.00016221179,0.0010492016,0.000011185752,0.0015388582],"genre_scores_gemma":[0.4314183,0.5609985,0.0032797917,0.0013025765,0.00037904587,0.0002922867,0.002073593,0.0000089835185,0.00024690383],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9966607,0.00094081205,0.0015007226,0.00037824348,0.00042306253,0.00009642707],"domain_scores_gemma":[0.9880122,0.004727912,0.0055864756,0.00022382413,0.0012665164,0.00018310692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032850294,0.0005533804,0.0016202874,0.010573032,0.00026346027,0.0011000544,0.00063643197,0.0006794785,0.0008181253],"category_scores_gemma":[0.007922163,0.00027897197,0.0011102114,0.006549511,0.0007298618,0.0015566858,0.0007721536,0.00033131085,0.00014514693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010579582,0.00009221909,0.24410057,0.42634547,0.008248165,0.0037066832,0.0011467984,0.00065744086,0.0061663915,0.0015910304,0.0060331947,0.3008541],"study_design_scores_gemma":[0.0004904542,0.0010693285,0.55575836,0.27720308,0.013908826,0.03734246,0.0041515785,0.00067514105,0.0025276956,0.0017666476,0.104978696,0.00012776339],"about_ca_topic_score_codex":0.0022596472,"about_ca_topic_score_gemma":0.0073403316,"teacher_disagreement_score":0.010573032,"about_ca_system_score_codex":0.0006358614,"about_ca_system_score_gemma":0.0028220343,"threshold_uncertainty_score":0.017373145},"labels":[],"label_agreement":null},{"id":"W4390122614","doi":"10.1212/nxi.0000000000200191","title":"CNS Inflammation as the First Sign of Complement Factor I Deficiency","year":2023,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Alexion Pharmaceuticals; Sanofi","keywords":"Medicine; Complement deficiency; Eculizumab; Inflammation; Immunology; Blockade; Complement system; Complement component 5; Internal medicine; Antibody; Receptor","score_opus":0.02458383152584899,"score_gpt":0.25655512497899613,"score_spread":0.23197129345314715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390122614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957845,0.014177842,0.003633011,0.0016778274,0.00024685162,0.00021324023,0.00035202326,0.0002525335,0.021601686],"genre_scores_gemma":[0.9958689,0.0019862643,0.0009591577,0.0002516463,0.00013624263,0.000014408125,0.00007584035,0.000007796952,0.0006996649],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997873,0.00003205596,0.000020902025,0.000044570916,0.000041395997,0.00007389522],"domain_scores_gemma":[0.99952006,0.00012507374,0.00015014375,0.00003583525,0.00005931093,0.00010954142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020073698,0.0007743008,0.00053884136,0.0007648898,0.0006149096,0.0005183094,0.0004183566,0.0011743434,0.0025438198],"category_scores_gemma":[0.0011501516,0.0002714578,0.00024402633,0.00040260763,0.0008230637,0.0006800286,0.00051558675,0.0012655931,0.0005722828],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024313101,0.00005166373,0.034936357,0.00020929043,0.000022168037,0.94621485,0.00026014887,0.00011555987,0.009699745,0.00050106,0.0010529732,0.006693073],"study_design_scores_gemma":[0.000022561166,0.0001717659,0.023477567,0.00009304995,0.000024298173,0.97105163,0.00016883494,0.00028085956,0.002852728,0.00032070457,0.0015237752,0.0000122807605],"about_ca_topic_score_codex":0.0015712162,"about_ca_topic_score_gemma":0.0016263716,"teacher_disagreement_score":0.0025438198,"about_ca_system_score_codex":0.0006195643,"about_ca_system_score_gemma":0.0006206905,"threshold_uncertainty_score":0.008509874},"labels":[],"label_agreement":null},{"id":"W4393294855","doi":"10.1212/nxi.0000000000200217","title":"Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"European Regional Development Fund; Science Foundation Ireland","keywords":"Natalizumab; Immunology; Multiple sclerosis; Immune system; Medicine; Antigen; Epstein–Barr virus; Dimethyl fumarate; Interferon; Cellular immunity; Monoclonal antibody; Virus; Antibody; Virology","score_opus":0.1204174294013099,"score_gpt":0.32691716269160925,"score_spread":0.20649973329029936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393294855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484587,0.0027407533,0.0004329099,0.000045602726,0.000024396651,0.00008618034,0.00028476873,0.000021903727,0.0015175742],"genre_scores_gemma":[0.9972964,0.0006445676,0.000793475,0.000079977115,0.000034086843,0.00007882568,0.00021461319,0.0000056125655,0.00085246825],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996234,0.0001589799,0.00003701842,0.000058765043,0.00008667616,0.000035111567],"domain_scores_gemma":[0.9994579,0.00017032961,0.00019904207,0.000031360978,0.00008462717,0.00005675588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057026703,0.00044089262,0.0003517636,0.00032275636,0.0001264278,0.00020709097,0.00014017249,0.00035655196,0.0029508097],"category_scores_gemma":[0.00068656093,0.000106782325,0.0002030917,0.00023231863,0.00013566184,0.0001802286,0.0001654747,0.00041259255,0.000463843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054970644,0.0013753005,0.24979955,0.00083647773,0.00043982614,0.00025363488,0.0003370222,0.00024687426,0.65356004,0.000041550957,0.0006194163,0.08699323],"study_design_scores_gemma":[0.0001282948,0.010941609,0.8777806,0.000053156717,0.0002011422,0.00096044084,0.000101318576,0.00023227624,0.10746377,0.000070997965,0.0020568634,0.0000094437355],"about_ca_topic_score_codex":0.00008828718,"about_ca_topic_score_gemma":0.00016436716,"teacher_disagreement_score":0.0029508097,"about_ca_system_score_codex":0.0000862532,"about_ca_system_score_gemma":0.000049738104,"threshold_uncertainty_score":0.009871483},"labels":[],"label_agreement":null},{"id":"W4394865947","doi":"10.1212/nxi.0000000000200227","title":"Trajectories of Inflammatory Markers and Post–COVID-19 Cognitive Symptoms","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; McGovern Medical School; National Institute on Aging; Georgia Clinical and Translational Science Alliance; Leonard M. Miller School of Medicine; University of Miami; York University; National Institutes of Health; Yale University; University of Texas Health Science Center at Houston; NYU Grossman School of Medicine; New York City Department of Health and Mental Hygiene","keywords":"Coronavirus disease 2019 (COVID-19); Inflammation; Cognition; Systemic inflammation; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Immunology; Internal medicine; Virology; Psychiatry; Disease","score_opus":0.00822088208963069,"score_gpt":0.2702423323860225,"score_spread":0.26202145029639184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394865947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988092,0.0003948788,0.00010264431,0.000053325824,0.000007093536,0.000030882053,0.00037242039,0.0000032177131,0.00022622003],"genre_scores_gemma":[0.99898714,0.00010840984,0.000120567034,0.000039687948,0.000017495995,0.000046064473,0.00058837683,0.0000011943191,0.00009105149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929416,0.00022449662,0.0000737995,0.00011738682,0.00011973324,0.00017030383],"domain_scores_gemma":[0.9964768,0.0005022634,0.0019533515,0.00018994174,0.00034332657,0.0005343229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016949204,0.0003579982,0.00055068376,0.0003475568,0.00029562012,0.00060793624,0.00029917335,0.0003175236,0.0012297957],"category_scores_gemma":[0.003044821,0.00012704352,0.0006607748,0.0004740235,0.00020205024,0.0003127273,0.00044978427,0.00088562764,0.00013592068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014445782,0.00069335714,0.97638947,0.00009104213,0.0005287074,0.000080453654,0.00007007963,0.00029745538,0.0008425386,0.00005014502,0.00031524032,0.006195894],"study_design_scores_gemma":[0.00025515942,0.0034235711,0.9952265,0.000017719296,0.00014006834,0.00009549654,0.000043319782,0.00026364697,0.00028376133,0.00005022174,0.00019318833,0.000007410392],"about_ca_topic_score_codex":0.0013592559,"about_ca_topic_score_gemma":0.0016469683,"teacher_disagreement_score":0.0016949204,"about_ca_system_score_codex":0.00043434452,"about_ca_system_score_gemma":0.00081141386,"threshold_uncertainty_score":0.008963704},"labels":[],"label_agreement":null},{"id":"W4394944574","doi":"10.1212/nxi.0000000000200222","title":"Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Mental Health; Medical Research Council; Canadian Institutes of Health Research; National Institute of Child Health and Human Development; University of California, San Diego; University of California, Los Angeles; National Institutes of Health; Université de Bordeaux; Agence Nationale de la Recherche; National Health and Medical Research Council; Commonwealth Scientific and Industrial Research Organisation; Alzheimer's Disease Neuroimaging Initiative; Centre National de la Recherche Scientifique; National Institute on Aging; Alzheimer's Association; Ministerio de Ciencia e Innovación; Northern California Institute for Research and Education; Michael J. Fox Foundation for Parkinson's Research","keywords":"Thalamus; Atrophy; Neurodegeneration; Neuroscience; Third ventricle; Multiple sclerosis; White matter; Medicine; Magnetic resonance imaging; Pathology; Psychology; Anatomy; Radiology","score_opus":0.035575270802179836,"score_gpt":0.2925264740360285,"score_spread":0.2569512032338487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394944574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867755,0.0002143829,0.0007173727,0.000012701444,0.0000020419525,0.0000040603763,0.00017273558,0.0000114404775,0.00018767822],"genre_scores_gemma":[0.9995437,0.000048820224,0.00021224646,0.000003277611,0.0000017485544,0.0000042901834,0.00011361775,0.0000029592597,0.000069176356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998926,0.000021979242,0.000008498022,0.000044607677,0.000017210328,0.000015180632],"domain_scores_gemma":[0.9996233,0.00009126635,0.00016565443,0.00003065319,0.000047964637,0.00004105607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002493604,0.00022530182,0.00018728957,0.0006757601,0.00017705178,0.00038352498,0.00021719396,0.0002491553,0.00087559293],"category_scores_gemma":[0.0013342199,0.000120300865,0.00017049634,0.00023657299,0.00027483408,0.0003078455,0.00035094024,0.00014721067,0.00013393014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020962611,0.000063372754,0.8967532,0.00013787288,0.00036392937,0.0018534069,0.0010887977,0.0057161627,0.060132597,0.00040345633,0.00033344323,0.03105753],"study_design_scores_gemma":[0.000014064751,0.0003192726,0.9774072,0.000030697924,0.0001125157,0.0032143365,0.00041306764,0.00998586,0.0072106705,0.00086234405,0.0004120975,0.000017869435],"about_ca_topic_score_codex":0.0040906062,"about_ca_topic_score_gemma":0.004623374,"teacher_disagreement_score":0.0040906062,"about_ca_system_score_codex":0.00035941132,"about_ca_system_score_gemma":0.00017020591,"threshold_uncertainty_score":0.00813359},"labels":[],"label_agreement":null},{"id":"W4399480087","doi":"10.1212/nxi.0000000000200272","title":"Advancing Knowledge in CNS Vasculitis","year":2024,"lang":"en","type":"editorial","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"F. Hoffmann-La Roche; Amicus Therapeutics; Teva Pharmaceutical Industries; Sanofi; AstraZeneca; Chugai Pharmaceutical; Amgen; Pfizer; GlaxoSmithKline","keywords":"Vasculitis; Neuroscience; Medicine; Psychology; Pathology; Disease","score_opus":0.005814270523213876,"score_gpt":0.26105731173517516,"score_spread":0.2552430412119613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399480087","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012332271,0.843083,0.0025900505,0.13060403,0.014025944,0.000022947845,0.00045237108,0.000156133,0.007832244],"genre_scores_gemma":[0.016526666,0.88025355,0.0038490405,0.04623201,0.05069989,0.00004623681,0.00049480906,0.000057796507,0.0018399182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669147,0.0011458304,0.00048177288,0.00054423575,0.0008414601,0.0002952586],"domain_scores_gemma":[0.9481222,0.03648926,0.0024361634,0.0017846739,0.0067933802,0.0043743015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009245391,0.0007208453,0.001428388,0.0059046815,0.0008633132,0.005045965,0.0020527635,0.006459975,0.01631438],"category_scores_gemma":[0.03466537,0.0004600745,0.0008957364,0.0028963855,0.0035163288,0.009206181,0.0043207165,0.00803019,0.003985808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017863051,0.000100415484,0.0031985587,0.008701095,0.00019054583,0.00076512154,0.0007448108,0.0005123158,0.0005748474,0.034134615,0.23704748,0.71385163],"study_design_scores_gemma":[0.000040176114,0.00007366497,0.0023364709,0.015453398,0.000087290384,0.0014464712,0.00058681594,0.0002949742,0.0002226083,0.052755482,0.9266502,0.000052405932],"about_ca_topic_score_codex":0.003252471,"about_ca_topic_score_gemma":0.0038311004,"teacher_disagreement_score":0.01631438,"about_ca_system_score_codex":0.0033162094,"about_ca_system_score_gemma":0.005865986,"threshold_uncertainty_score":0.054577053},"labels":[],"label_agreement":null},{"id":"W4399832607","doi":"10.1212/nxi.0000000000200271","title":"Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Ministero della Salute; Multiple Sclerosis Society of Canada; Eli Lilly and Company; Bristol-Myers Squibb; Fondazione Italiana Sclerosi Multipla; Biogen; Celgene; Alexion Pharmaceuticals; Sanofi; Horizon Therapeutics; Novo Nordisk; Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Cerebrospinal fluid; Gray (unit); White matter; Neuroscience; Medicine; Pathology; Psychology; Magnetic resonance imaging; Radiology","score_opus":0.03564745854315858,"score_gpt":0.27134653822815824,"score_spread":0.23569907968499965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399832607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995036,0.000175774,0.00015690841,0.000008978628,9.2071804e-7,0.0000043020195,0.000047039444,0.0000047797325,0.000097596356],"genre_scores_gemma":[0.999686,0.00003930429,0.00019018108,0.0000029029145,0.0000011047607,0.000003276115,0.000033646294,0.0000016277276,0.00004211924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999131,0.000026458289,0.000008672125,0.000018536542,0.000020234878,0.000012951481],"domain_scores_gemma":[0.99958783,0.000085362866,0.00020244344,0.000022645328,0.000049136175,0.00005257364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033512097,0.0002017632,0.00015819649,0.0005422997,0.00013984754,0.00035981313,0.0001155546,0.00016202944,0.0007037699],"category_scores_gemma":[0.00094413274,0.0001422074,0.00009511541,0.00026664764,0.00023030592,0.00025706083,0.0002912745,0.00018892261,0.000084336505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036896314,0.00015974048,0.9095857,0.00017811605,0.00033562214,0.0004134113,0.00072634034,0.0010128332,0.062443018,0.00014212572,0.0001749534,0.021138486],"study_design_scores_gemma":[0.000009156275,0.00018440219,0.99655676,0.000005834932,0.000031265386,0.00033999563,0.00009584375,0.00039941014,0.0021643625,0.00012795745,0.00008068999,0.0000043960613],"about_ca_topic_score_codex":0.0016827383,"about_ca_topic_score_gemma":0.0018034813,"teacher_disagreement_score":0.0016827383,"about_ca_system_score_codex":0.00019496458,"about_ca_system_score_gemma":0.00016771733,"threshold_uncertainty_score":0.0033459067},"labels":[],"label_agreement":null},{"id":"W4400109826","doi":"10.1212/nxi.0000000000200269","title":"Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness <i>z</i> Scores","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Instituto de Salud Carlos III; Chugai Pharmaceutical; Guthy-Jackson Charitable Foundation; Ipsen; Sanofi Genzyme; Stiftung Charité; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Biogen; Celgene; Alexion Pharmaceuticals; National Multiple Sclerosis Society; Horizon Therapeutics; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Bristol-Myers Squibb; Arthur Arnstein Stiftung; Eli Lilly and Company; Allergan; National Institutes of Health; Stichting MS Research; Bayer HealthCare; European Commission; Sanofi; Deutsche Forschungsgemeinschaft","keywords":"Retinal; Multiple sclerosis; Disease; Layer (electronics); Medicine; Physical medicine and rehabilitation; Gerontology; Internal medicine; Ophthalmology; Psychiatry; Materials science; Composite material","score_opus":0.057484998709608555,"score_gpt":0.2863296623488212,"score_spread":0.22884466363921263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400109826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658126,0.000833481,0.0013265192,0.00004978248,0.0000112226735,0.000018802937,0.00034082192,0.000023267829,0.00081488927],"genre_scores_gemma":[0.9990343,0.000076294076,0.00065166893,0.000006403859,0.0000071186537,0.0000084995745,0.00013317805,0.0000023939697,0.00008010838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894935,0.00054801704,0.00012586612,0.0001480163,0.00016797993,0.000060699273],"domain_scores_gemma":[0.99479395,0.0020749255,0.0020367487,0.0003842024,0.00047882664,0.00023128743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040876386,0.0004646261,0.00033914414,0.00176799,0.00016435808,0.00080559636,0.00029467014,0.00035706337,0.0012773662],"category_scores_gemma":[0.008030684,0.00013681165,0.0005088952,0.0008480024,0.00022470714,0.00044160915,0.000501483,0.00040286567,0.00019256155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007058692,0.000022875247,0.9898997,0.00003224094,0.00018428685,0.000027065958,0.000039541654,0.00037005614,0.00033160183,0.000036393107,0.00009649106,0.008253865],"study_design_scores_gemma":[0.000027319851,0.00035293744,0.99399805,0.000030321236,0.00025433337,0.00030580754,0.000100795965,0.0034819725,0.00093466864,0.00022320227,0.00027828562,0.000012181381],"about_ca_topic_score_codex":0.0011360169,"about_ca_topic_score_gemma":0.0016991809,"teacher_disagreement_score":0.0040876386,"about_ca_system_score_codex":0.00021772827,"about_ca_system_score_gemma":0.0002442719,"threshold_uncertainty_score":0.02161777},"labels":[],"label_agreement":null},{"id":"W4402507349","doi":"10.1212/nxi.0000000000200311","title":"IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Pacific Northwest National Laboratory; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Center for Complementary and Integrative Health; National Institute on Aging; Alzheimer's Disease Research Center, Emory University; National Institutes of Health; Canadian Institutes of Health Research; Jazz Pharmaceuticals; Prothena; Portland VA Research Foundation; Demensförbundet; Idorsia Pharmaceuticals; National Alliance for Research on Schizophrenia and Depression; National Science Foundation; Georgia Research Alliance; Michael J. Fox Foundation for Parkinson's Research; Emory University; Biogen; Ono Pharmaceutical; U.S. Department of Defense; American Sleep Medicine Foundation; Eisai; Collins Medical Trust; National Institute of General Medical Sciences; Sunovion; American Heart Association; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; U.S. Department of Veterans Affairs","keywords":"REM sleep behavior disorder; Parasomnia; Sleep (system call); Medicine; Audiology; Psychology; Polysomnography; Neuroscience; Psychiatry; Electroencephalography; Computer science","score_opus":0.011168504079300472,"score_gpt":0.2581972583216906,"score_spread":0.24702875424239013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402507349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993488,0.00021042422,0.00005257646,0.000012684637,0.0000036286613,0.000002812097,0.00010518919,0.0000044163144,0.00025958856],"genre_scores_gemma":[0.9997129,0.000037262136,0.00005804944,0.000010109719,0.000004316257,0.0000021794351,0.00009753593,0.000001398396,0.000076200486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971956,0.000052275722,0.000032669104,0.000106277585,0.000052758485,0.000036463443],"domain_scores_gemma":[0.9993716,0.00010265305,0.00033012626,0.000036788315,0.00008324156,0.00007557607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035033585,0.00024551363,0.00021990262,0.00085999136,0.00032146534,0.00035189826,0.00035049554,0.00041156315,0.0025430117],"category_scores_gemma":[0.0009533074,0.000120214856,0.00020537767,0.00052971725,0.0002245358,0.00020685811,0.00032153065,0.00020723042,0.0002929276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013425353,0.000014476347,0.99674904,0.000009793562,0.000016497323,0.00028085342,0.00006472257,0.0000150012,0.0012680291,0.000009293978,0.000056120083,0.0013819635],"study_design_scores_gemma":[0.0000032957978,0.00008860974,0.9974832,0.000006873685,0.000015298312,0.0018238345,0.000099586614,0.00009856918,0.00022501705,0.000015056352,0.00013862633,0.000001928338],"about_ca_topic_score_codex":0.0017408693,"about_ca_topic_score_gemma":0.0020629044,"teacher_disagreement_score":0.0025430117,"about_ca_system_score_codex":0.00019591647,"about_ca_system_score_gemma":0.00009211635,"threshold_uncertainty_score":0.008507192},"labels":[],"label_agreement":null},{"id":"W4403320599","doi":"10.1212/nxi.0000000000200321","title":"Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"UCB Pharma; Sanofi Genzyme; EMD Serono; Genentech; Biogen; Celgene; Alexion Pharmaceuticals; Shionogi; Sanofi; Teva Pharmaceutical Industries; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Dosing; Natalizumab; Multiple sclerosis; Pharmacodynamics; Pharmacokinetics; Medicine; Relapsing remitting; Pharmacology; Immunology","score_opus":0.0320156708101307,"score_gpt":0.2740794635867067,"score_spread":0.242063792776576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403320599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986234,0.00051592937,0.00038732274,0.000046814257,0.000010157407,0.00006722411,0.00012275686,0.000022300896,0.0002041797],"genre_scores_gemma":[0.99878377,0.00015555057,0.000511434,0.00004926846,0.000011938806,0.0000873623,0.00012821406,0.000007068586,0.00026551654],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991609,0.0004322444,0.000039659586,0.00015130216,0.00014630011,0.00006962027],"domain_scores_gemma":[0.99886596,0.00033352635,0.00048801434,0.000096961776,0.000057822377,0.00015777555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017126545,0.00030120532,0.00069042866,0.00019388324,0.0001287898,0.0005853048,0.00041781593,0.000528105,0.0010434595],"category_scores_gemma":[0.00269208,0.00029061295,0.0005918939,0.00018496119,0.00027929933,0.00044852737,0.00014556356,0.0011509603,0.0003132083],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53250074,0.011149685,0.07943221,0.00038817152,0.0021469775,0.00019672212,0.0005103289,0.011461005,0.15240242,0.0002997295,0.0013349716,0.20817702],"study_design_scores_gemma":[0.053742167,0.4610999,0.39633226,0.00007210301,0.0022641316,0.0011313992,0.00015852763,0.03312705,0.045907784,0.00080281374,0.005188323,0.0001736434],"about_ca_topic_score_codex":0.0004854343,"about_ca_topic_score_gemma":0.00061796553,"teacher_disagreement_score":0.0017126545,"about_ca_system_score_codex":0.00060139556,"about_ca_system_score_gemma":0.00043792953,"threshold_uncertainty_score":0.009057462},"labels":[],"label_agreement":null},{"id":"W4403673243","doi":"10.1212/nxi.0000000000200319","title":"Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Pfizer Foundation; EMD Serono; Horizon Therapeutics; National Multiple Sclerosis Society; International Progressive MS Alliance; Genentech; Epilepsy Society; Ontario Institute for Regenerative Medicine; National Institutes of Health; Myelin Repair Foundation; Kiniksa Pharmaceuticals; Shionogi; Arthritis Society; Idorsia Pharmaceuticals; Children's Hospital of Philadelphia; University of Pennsylvania; Alexion Pharmaceuticals; Pfizer; Biogen; Eli Lilly and Company; U.S. Department of Defense; Sanofi; Hospital for Sick Children; Multiple Sclerosis Society of Canada; Amgen","keywords":"Choroid plexus; Multiple sclerosis; Medicine; Volume (thermodynamics); Internal medicine; Central nervous system; Physics","score_opus":0.043185588001180206,"score_gpt":0.27797529640896884,"score_spread":0.23478970840778862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403673243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645776,0.0016416725,0.00047277144,0.00003384371,0.0000052280443,0.000010208542,0.00066241506,0.000039750586,0.0006763973],"genre_scores_gemma":[0.99806243,0.00046671025,0.00090222846,0.0000077058285,0.0000049511355,0.000015506816,0.00034518517,0.000009714372,0.00018565133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997737,0.000034824094,0.000015187833,0.00008474825,0.00006987856,0.000021825786],"domain_scores_gemma":[0.9991265,0.0001348825,0.00053555734,0.000036356003,0.00009789655,0.000068786074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033915188,0.00034259885,0.00021709687,0.0010620245,0.00018913475,0.0004674225,0.00024146037,0.0002982603,0.0017237066],"category_scores_gemma":[0.0012419678,0.00020896817,0.00018050635,0.00056110346,0.00029195013,0.00044889053,0.0003634376,0.00027485218,0.00015401728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007752666,0.000042374304,0.95041263,0.00019198659,0.00018695189,0.0010738078,0.00037061406,0.0013362983,0.022753678,0.00013652984,0.00047040058,0.022249473],"study_design_scores_gemma":[0.0000063133352,0.000091163594,0.9947777,0.000018079723,0.00002390195,0.0019831841,0.00012002351,0.0005253998,0.0019033023,0.00005925049,0.00048663956,0.00000501004],"about_ca_topic_score_codex":0.006193771,"about_ca_topic_score_gemma":0.0057038055,"teacher_disagreement_score":0.006193771,"about_ca_system_score_codex":0.00054554874,"about_ca_system_score_gemma":0.00028716493,"threshold_uncertainty_score":0.0123153925},"labels":[],"label_agreement":null},{"id":"W4403673251","doi":"10.1212/nxi.0000000000200328","title":"Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Sanofi Genzyme; Mitsubishi Tanabe Pharma Corporation; Fondation Charcot; Univerzita Karlova v Praze; Karadeniz Teknik Üniversitesi; Eisai; Sanofi; Multiple Sclerosis International Federation; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Murdoch University; Multiple Sclerosis Australia; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Všeobecná Fakultní Nemocnice v Praze; Biogen; Celgene; Hunter New England Local Health District; Sveučilište u Zagrebu; F. Hoffmann-La Roche; Medicinski Fakultet, Sveučilište u Zagrebu; Monash University; Alexion Pharmaceuticals; Vlaamse regering; National Multiple Sclerosis Society; Amicus Therapeutics; Medical Research Council; Teva Pharmaceutical Industries; Novartis Pharma; European Commission","keywords":"Ocrelizumab; Medicine; Disease; Multiple sclerosis; Pregnancy; Internal medicine; Immunology; Rituximab","score_opus":0.04454560062272642,"score_gpt":0.2798303811565144,"score_spread":0.23528478053378796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403673251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989237,0.00029362965,0.000038128434,0.00003278049,0.0000045515126,0.000008590618,0.00024374345,0.0000024662907,0.0004523364],"genre_scores_gemma":[0.9994049,0.00022793999,0.000070039154,0.00001976578,0.0000058468772,0.000011310702,0.00015757533,0.0000010443797,0.000101504236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964595,0.00010979254,0.000040519895,0.000074953874,0.000059060883,0.00006969009],"domain_scores_gemma":[0.99931216,0.00014472792,0.00038292643,0.000046345165,0.000044736385,0.0000690838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005414733,0.00014634489,0.00022359706,0.0004398295,0.0002864409,0.00034905237,0.0002477182,0.00028471116,0.0008475262],"category_scores_gemma":[0.0022832658,0.00021785827,0.00025955637,0.0006193949,0.00020360822,0.00019598838,0.00022700785,0.0003504902,0.00015930302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014598403,0.000019063753,0.99804866,0.000005465176,0.000013485455,0.00022917612,0.000068966394,0.000011318492,0.00009278389,0.00000752272,0.00004576197,0.0013117042],"study_design_scores_gemma":[0.000010173017,0.00015183263,0.9974262,0.000013509318,0.00003502888,0.0016631831,0.0002361701,0.00013694495,0.000096422926,0.000017310233,0.0002104623,0.0000027945237],"about_ca_topic_score_codex":0.0047581955,"about_ca_topic_score_gemma":0.0033758825,"teacher_disagreement_score":0.0047581955,"about_ca_system_score_codex":0.0002685005,"about_ca_system_score_gemma":0.00025377938,"threshold_uncertainty_score":0.009461045},"labels":[],"label_agreement":null},{"id":"W4405519437","doi":"10.1212/nxi.0000000000200357","title":"Clinical Characterization and Prognostic Risk Factors of Susac Syndrome","year":2024,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.015265332823995956,"score_gpt":0.2775201621488703,"score_spread":0.2622548293248744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405519437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925846,0.00033968574,0.00004603126,0.000026767524,0.0000033184128,0.0000045398046,0.00005910683,0.0000025875886,0.00025947203],"genre_scores_gemma":[0.99965394,0.00008786204,0.00005754286,0.000007456246,0.000013335149,0.000004320607,0.00013765901,0.0000010367023,0.000036862075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996038,0.000101888065,0.000058631107,0.000087818684,0.0000683037,0.00007964368],"domain_scores_gemma":[0.99790597,0.00043873696,0.0009050384,0.00006459748,0.00020505204,0.00048061644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004178285,0.00053800584,0.00044430414,0.0012232979,0.00044822096,0.00052266155,0.00031570886,0.0005982681,0.0016032845],"category_scores_gemma":[0.0025267617,0.00019945015,0.00030769466,0.000834846,0.0004110568,0.0005055681,0.00042338844,0.0003689716,0.00024108404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011657148,0.000014541442,0.9978823,0.0000034652053,0.000009900565,0.00084205944,0.000025076431,0.000028012368,0.00034251125,0.000012169162,0.000030926567,0.0006924676],"study_design_scores_gemma":[0.000009093804,0.00014300566,0.99060553,0.0000095644955,0.000016029251,0.008644418,0.00014137654,0.00018912047,0.00009249497,0.000045750312,0.00009811254,0.0000055435144],"about_ca_topic_score_codex":0.0010238142,"about_ca_topic_score_gemma":0.0008287205,"teacher_disagreement_score":0.0016032845,"about_ca_system_score_codex":0.00021233637,"about_ca_system_score_gemma":0.00034163604,"threshold_uncertainty_score":0.0053634644},"labels":[],"label_agreement":null},{"id":"W4409916110","doi":"10.1212/nxi.0000000000200404","title":"Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Relapsing remitting; Multiple sclerosis; Extracellular vesicles; Extracellular; Extracellular vesicle; Disease; Medicine; Neuroscience; Immunology; Chemistry; Biology; Pathology; Microvesicles; Cell biology; Biochemistry","score_opus":0.012887176617179853,"score_gpt":0.21499011309462368,"score_spread":0.20210293647744382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409916110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988864,0.0006662691,0.0001460344,0.000008586808,0.0000035940443,0.0000063537195,0.00008888099,0.000009749131,0.00018411601],"genre_scores_gemma":[0.9993618,0.00012824424,0.00025892313,0.0000089338655,0.000006365024,0.000007265967,0.00012564016,0.0000019083511,0.00010098003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998441,0.000027806953,0.000031525455,0.00004807929,0.000027822605,0.000020727335],"domain_scores_gemma":[0.9995499,0.000063910076,0.00025135675,0.000018893585,0.000060216582,0.000055739743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026887684,0.00028589138,0.0002838233,0.0009899857,0.00021791915,0.00036329366,0.0001179733,0.00039168823,0.0010092484],"category_scores_gemma":[0.0005153968,0.000094468916,0.0001759941,0.00041997145,0.00018718619,0.00021156864,0.00023028944,0.00023273719,0.00018585325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003504908,0.00017208618,0.71034867,0.00033010545,0.00030882482,0.0015358856,0.00056518783,0.00039087058,0.26113808,0.00007597473,0.00023170265,0.021397771],"study_design_scores_gemma":[0.000024601004,0.00068298535,0.9804059,0.000022571898,0.000088758046,0.004720225,0.00025029617,0.00065812794,0.012565539,0.000094984505,0.00047503097,0.000010938984],"about_ca_topic_score_codex":0.00031467158,"about_ca_topic_score_gemma":0.00027422293,"teacher_disagreement_score":0.0010092484,"about_ca_system_score_codex":0.00014334719,"about_ca_system_score_gemma":0.000057073998,"threshold_uncertainty_score":0.003376305},"labels":[],"label_agreement":null},{"id":"W4410141120","doi":"10.1212/nxi.0000000000200403","title":"Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute on Aging","keywords":"Identification (biology); Profiling (computer programming); Computational biology; Biology; Medicine; Computer science; Ecology","score_opus":0.0055203699811649356,"score_gpt":0.22131881555901844,"score_spread":0.21579844557785352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410141120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897623,0.00032679562,0.0002891595,0.000026375834,0.000004133085,0.0000190647,0.00012473739,0.0000050249564,0.00022835625],"genre_scores_gemma":[0.99896574,0.0001336529,0.0005044594,0.000025468238,0.0000134593865,0.00001477352,0.00027628895,0.0000023406467,0.000063780935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996792,0.0000531045,0.000048148995,0.00008825939,0.00005793417,0.000073434414],"domain_scores_gemma":[0.9992379,0.00011407213,0.0003510996,0.00005356543,0.00009040956,0.00015299646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032157786,0.000447016,0.0005750511,0.0010985757,0.00049518887,0.0007166752,0.00020207163,0.00038568783,0.0010847275],"category_scores_gemma":[0.0011077034,0.00011774167,0.00029989754,0.0006848968,0.00042748186,0.0003521862,0.0005551142,0.00034309944,0.00021121447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011287451,0.00006492854,0.9801002,0.00004526388,0.000046180143,0.0015325643,0.00013494832,0.0001221872,0.011324214,0.000069947,0.00007938432,0.0053514913],"study_design_scores_gemma":[0.00004829996,0.0004893971,0.986777,0.000030104407,0.00007143707,0.008158389,0.0006337209,0.000806589,0.0021908798,0.00020719059,0.00057342893,0.00001350488],"about_ca_topic_score_codex":0.0005455647,"about_ca_topic_score_gemma":0.0006259245,"teacher_disagreement_score":0.0010985757,"about_ca_system_score_codex":0.00028546786,"about_ca_system_score_gemma":0.00033254435,"threshold_uncertainty_score":0.0036287308},"labels":[],"label_agreement":null},{"id":"W4410849524","doi":"10.1212/nxi.0000000000200413","title":"Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; University of Saskatchewan; University of Calgary","funders":"","keywords":"Bruton's tyrosine kinase; Tyrosine kinase; Multiple sclerosis; Medicine; Neuroscience; Biology; Internal medicine; Immunology; Receptor","score_opus":0.039710728306211446,"score_gpt":0.27725753091143246,"score_spread":0.237546802605221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410849524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98048854,0.008166354,0.0029538479,0.0005190261,0.00017982557,0.00056457653,0.0017087891,0.00037178956,0.005047273],"genre_scores_gemma":[0.9741616,0.0076615224,0.005412232,0.00036935473,0.00008194661,0.00093608507,0.0036956174,0.000051127543,0.0076303724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995097,0.000080135724,0.0000624128,0.000096244614,0.00013899834,0.000112415066],"domain_scores_gemma":[0.9996767,0.000027102837,0.000098681514,0.0000480322,0.000048257225,0.00010123742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000534555,0.0015427963,0.0009024656,0.0021607443,0.0006988036,0.0006224678,0.00046564054,0.0010974993,0.0021020782],"category_scores_gemma":[0.00022226648,0.00028503517,0.0007347213,0.00079035875,0.00061201333,0.0005849587,0.0005132924,0.0017078243,0.0006926635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005667464,0.0018350802,0.0030023544,0.0005567487,0.000104973355,0.0005845047,0.00011681132,0.00038894464,0.9765223,0.000468538,0.0008138849,0.009938323],"study_design_scores_gemma":[0.00152241,0.038024787,0.053536203,0.00027727804,0.0007215148,0.011178381,0.00034098266,0.0031317363,0.8601552,0.0013523656,0.029643077,0.00011596075],"about_ca_topic_score_codex":0.0012541381,"about_ca_topic_score_gemma":0.0021399935,"teacher_disagreement_score":0.0021607443,"about_ca_system_score_codex":0.00078349584,"about_ca_system_score_gemma":0.00067233876,"threshold_uncertainty_score":0.007032156},"labels":[],"label_agreement":null},{"id":"W4411985508","doi":"10.1212/nxi.0000000000200426","title":"Peripheral HLA-DR <sup>hi</sup> CD141 <sup>+</sup> Classical Monocytes Predict Relapse Risk and Worsening in Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Physics; Human leukocyte antigen; Peripheral; Medicine; Immunology; Internal medicine; Antigen","score_opus":0.03308957877647927,"score_gpt":0.2663902908932061,"score_spread":0.23330071211672682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411985508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871576,0.0006004953,0.0002834576,0.00004362728,0.0000050621397,0.000009473786,0.00009338903,0.0000085395795,0.0002400874],"genre_scores_gemma":[0.99915767,0.00009350817,0.00043990737,0.00002527133,0.000012652843,0.000008398209,0.00012292438,0.0000016272537,0.00013812761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997509,0.00009618213,0.000030711886,0.000057299923,0.00003591155,0.000028923378],"domain_scores_gemma":[0.9990528,0.0002451928,0.0003252731,0.000070364295,0.00013628005,0.00017008679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096503296,0.0002716092,0.00023946301,0.00060874945,0.00019013682,0.00047977557,0.00020699207,0.00037724877,0.002030814],"category_scores_gemma":[0.0017517704,0.00010116176,0.00017248503,0.00038654823,0.00020223779,0.00025049728,0.00031978596,0.0004249642,0.00036875537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023484852,0.00017288624,0.96567875,0.000087216,0.00012695759,0.00009835159,0.00010937313,0.00034752642,0.008621508,0.000045377394,0.0004224162,0.021941204],"study_design_scores_gemma":[0.00002936003,0.0003677351,0.9946648,0.000023329967,0.000090000256,0.00047304502,0.00015223672,0.0015762753,0.0021255065,0.00018081232,0.00030957643,0.0000073062265],"about_ca_topic_score_codex":0.00053530326,"about_ca_topic_score_gemma":0.00084192207,"teacher_disagreement_score":0.002030814,"about_ca_system_score_codex":0.00011932381,"about_ca_system_score_gemma":0.00014562313,"threshold_uncertainty_score":0.006793797},"labels":[],"label_agreement":null},{"id":"W4412796828","doi":"10.1212/nxi.0000000000200450","title":"Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neuromyelitis optica; Extension (predicate logic); Spectrum disorder; Term (time); Open label; Medicine; Broad spectrum; Spectrum (functional analysis); Dermatology; Internal medicine; Psychiatry; Computer science; Multiple sclerosis; Adverse effect; Physics; Chemistry","score_opus":0.022535761892066714,"score_gpt":0.2970093437663452,"score_spread":0.2744735818742785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412796828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962016,0.0018835046,0.00011133776,0.00012757671,0.000035480974,0.00035632297,0.00078406575,0.000013478352,0.0004867045],"genre_scores_gemma":[0.9946571,0.0010772559,0.0004896061,0.00033332486,0.000118394164,0.0006362887,0.002121086,0.000009846784,0.0005570141],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99912304,0.00046817298,0.00009985761,0.00012076688,0.00010058573,0.0000875726],"domain_scores_gemma":[0.99761754,0.0003866875,0.0009889439,0.00022308955,0.0002350285,0.00054871937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031203052,0.0008850325,0.0015149646,0.000280627,0.00036455947,0.0007125536,0.0005121332,0.0007378932,0.0019690346],"category_scores_gemma":[0.0015640619,0.00037538508,0.0017485189,0.00033459775,0.0004784865,0.0006339889,0.0003955667,0.0015415407,0.0004450769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8606341,0.008609435,0.045394044,0.0010567801,0.0033019376,0.00024179996,0.00031170464,0.0008005097,0.021005359,0.00008211443,0.001868016,0.05669423],"study_design_scores_gemma":[0.49286023,0.25963914,0.23449406,0.00014864604,0.0038748046,0.0005950771,0.00014833902,0.0011901208,0.002703421,0.00012486718,0.004138098,0.00008324605],"about_ca_topic_score_codex":0.0006443439,"about_ca_topic_score_gemma":0.0014849338,"teacher_disagreement_score":0.0031203052,"about_ca_system_score_codex":0.00057435984,"about_ca_system_score_gemma":0.0011872827,"threshold_uncertainty_score":0.016501963},"labels":[],"label_agreement":null},{"id":"W4412984063","doi":"10.1212/nxi.0000000000200457","title":"Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Toxic Organic Pollutants Impact","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Aryl hydrocarbon receptor; Agonist; Hydrocarbon; Disease; Aryl; Receptor; Chemistry; Medicine; Internal medicine; Pharmacology; Organic chemistry; Biochemistry","score_opus":0.005072107767123717,"score_gpt":0.19303847935466703,"score_spread":0.1879663715875433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412984063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987857,0.00064248993,0.00009755258,0.00002584218,0.000005043863,0.000004382393,0.00012593015,0.00000687079,0.0003062311],"genre_scores_gemma":[0.99958545,0.000109125765,0.000087428496,0.000015120724,0.000006932352,0.0000037122488,0.00010624894,7.3946916e-7,0.0000852935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998079,0.000037648148,0.00003332948,0.000053597774,0.000040542312,0.00002702372],"domain_scores_gemma":[0.9994486,0.00010551568,0.00027457808,0.000022428892,0.000056784054,0.00009193513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019512192,0.0002614948,0.00037318195,0.00047412718,0.0002736199,0.0002957092,0.00014174548,0.00033978623,0.0010989252],"category_scores_gemma":[0.0007694231,0.000114035574,0.00021265203,0.00040162343,0.00020290607,0.00023513402,0.00023103236,0.0003222469,0.00017080322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041483145,0.00003760679,0.99190384,0.000022915461,0.000054378223,0.00019256759,0.000067561756,0.000048885337,0.0039240033,0.000008049402,0.000065736625,0.0032596332],"study_design_scores_gemma":[0.0000063856446,0.00017687978,0.99859923,0.0000033320741,0.000021411322,0.0006613026,0.000068430556,0.00008472349,0.00024495224,0.000011180787,0.000120396384,0.0000018825898],"about_ca_topic_score_codex":0.0007353545,"about_ca_topic_score_gemma":0.001040432,"teacher_disagreement_score":0.0010989252,"about_ca_system_score_codex":0.00015305981,"about_ca_system_score_gemma":0.00010793155,"threshold_uncertainty_score":0.0036762953},"labels":[],"label_agreement":null},{"id":"W4415200142","doi":"10.1212/nxi.0000000000200499","title":"Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Multiple sclerosis; Intrathecal; Immune system; Disease; Antibody; Genotype; Allele; Gene; Genetic variants","score_opus":0.03524138278745751,"score_gpt":0.2808802101617838,"score_spread":0.24563882737432632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415200142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734676,0.00064349733,0.0009026819,0.0001343626,0.000011342571,0.000008179883,0.00044393566,0.000017344546,0.00049199903],"genre_scores_gemma":[0.9989454,0.0001250865,0.00052875857,0.00001768639,0.000015391235,0.000006935621,0.00017735887,0.00000448494,0.00017882102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938595,0.00015186585,0.000062920924,0.0002479183,0.00008350363,0.00006780069],"domain_scores_gemma":[0.99863166,0.00046989022,0.0006267734,0.00008837569,0.000055000342,0.00012823389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052766525,0.0006443746,0.00033633292,0.00077674736,0.00040216342,0.0004162131,0.00036692314,0.0007258097,0.0043564816],"category_scores_gemma":[0.0019019047,0.00015605154,0.0008439634,0.0011697108,0.00036808013,0.00014287421,0.00032244297,0.0004915466,0.00024559954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013480027,0.00011578468,0.9713038,0.00009558128,0.0015939948,0.0024916765,0.00026411182,0.0010014321,0.013246086,0.00044426814,0.00030883716,0.0077865194],"study_design_scores_gemma":[0.000041313913,0.00013214276,0.99415165,0.000028769702,0.00046161978,0.002591714,0.000050911472,0.0009999303,0.0007208453,0.00038371934,0.00042735113,0.000009943292],"about_ca_topic_score_codex":0.004154103,"about_ca_topic_score_gemma":0.0030070853,"teacher_disagreement_score":0.0043564816,"about_ca_system_score_codex":0.00020601565,"about_ca_system_score_gemma":0.00036171539,"threshold_uncertainty_score":0.014573872},"labels":[],"label_agreement":null},{"id":"W4416328073","doi":"10.1212/nxi.0000000000200449","title":"Spinal Cord Leptomeningeal Enhancement as a Marker of Extensive Spinal Cord Involvement in Children With MOGAD","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Ottawa Hospital; Montreal Neurological Institute and Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Spinal cord; Cord; Central nervous system disease; Central nervous system; Lesion","score_opus":0.01927620104970906,"score_gpt":0.2810440360805897,"score_spread":0.26176783503088064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416328073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993783,0.0002190782,0.000027425875,0.000021616057,0.0000017603963,0.000006965943,0.00004807491,0.0000021683106,0.00029447235],"genre_scores_gemma":[0.99965096,0.00010117759,0.00013054987,0.000010313677,0.00000471382,0.000004820945,0.00005919979,9.421249e-7,0.000037275357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995552,0.00010630724,0.000044743683,0.000076203,0.00012999099,0.000087476976],"domain_scores_gemma":[0.99800533,0.00047366988,0.0009363734,0.000055031043,0.00019904149,0.00033046474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007153555,0.00033837502,0.0002514842,0.0009965716,0.0003212313,0.00045944558,0.00036095755,0.0005038903,0.0014990894],"category_scores_gemma":[0.0028535775,0.00021096572,0.00018874383,0.00059568917,0.0006043202,0.0005193061,0.0003986375,0.0004868474,0.00014347832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053033946,0.000013418241,0.99824345,0.0000122433175,0.000007721469,0.00048339056,0.000082984414,0.000014778391,0.00043518658,0.000008214673,0.000030404368,0.0006152809],"study_design_scores_gemma":[0.0000031581592,0.000077424214,0.99686205,0.000011184725,0.000010405484,0.0026302878,0.00018869691,0.000047821108,0.00009308945,0.000007229774,0.00006689889,0.0000017985725],"about_ca_topic_score_codex":0.008938039,"about_ca_topic_score_gemma":0.014976539,"teacher_disagreement_score":0.008938039,"about_ca_system_score_codex":0.00043697938,"about_ca_system_score_gemma":0.0006185288,"threshold_uncertainty_score":0.017772019},"labels":[],"label_agreement":null},{"id":"W7116829828","doi":"10.1212/nxi.0000000000200532","title":"Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Production (economics); Signal transduction; Production model; Expression (computer science)","score_opus":0.012773080467835582,"score_gpt":0.2258044764728503,"score_spread":0.2130313960050147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116829828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923752,0.0041429503,0.00062026636,0.00016658506,0.000075402364,0.000018693374,0.0003037968,0.000024721845,0.0022724227],"genre_scores_gemma":[0.99688905,0.0013005887,0.00035441658,0.000076780336,0.000044839893,0.00002439503,0.00013634513,0.00000835462,0.0011651722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998312,0.000036825775,0.000011865606,0.000041249798,0.000027192418,0.000051564948],"domain_scores_gemma":[0.99986756,0.000020504278,0.000049685394,0.000010213412,0.000017833447,0.00003407199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019621201,0.00025327032,0.00018648928,0.00021116718,0.0001236425,0.0003517195,0.00014088966,0.00016233594,0.0029416909],"category_scores_gemma":[0.0002559913,0.000097996366,0.00020636324,0.00012723774,0.00016369835,0.00015298452,0.00013920853,0.0002933457,0.0004971291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043671844,0.0002596958,0.044375528,0.0002968476,0.000065493085,0.00061261706,0.00016663046,0.00014888361,0.90959036,0.0003539898,0.0007816143,0.038981166],"study_design_scores_gemma":[0.00033000298,0.0032245887,0.6181591,0.00010814236,0.0003122605,0.0047234446,0.0007803721,0.0020770407,0.35879108,0.00086773565,0.010592296,0.00003388469],"about_ca_topic_score_codex":0.00016022299,"about_ca_topic_score_gemma":0.00021610454,"teacher_disagreement_score":0.0029416909,"about_ca_system_score_codex":0.000130852,"about_ca_system_score_gemma":0.00019837836,"threshold_uncertainty_score":0.009840965},"labels":[],"label_agreement":null},{"id":"W7116887376","doi":"10.1212/nxi.0000000000200534","title":"Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab","year":2025,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta; University of Saskatchewan","funders":"","keywords":"Ocrelizumab; Encephalitis; Hypogammaglobulinemia; Enterovirus; Multiple sclerosis; Complication; Viral disease","score_opus":0.020060701755528376,"score_gpt":0.2616693950316127,"score_spread":0.2416086932760843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116887376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970741,0.0007140572,0.000050409784,0.00020392126,0.000019283865,0.000020141648,0.00019322203,0.000007888154,0.0017169248],"genre_scores_gemma":[0.99922466,0.00029394226,0.000053527903,0.00013241246,0.000027769272,0.000009234386,0.0001212986,0.0000012023534,0.00013589412],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.999699,0.000053941843,0.000035991936,0.00006008919,0.00007225799,0.00007873997],"domain_scores_gemma":[0.99957114,0.000045629815,0.00023968995,0.000014263356,0.00004678724,0.00008234999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002645802,0.0002315292,0.0002745536,0.00060111185,0.0006849467,0.0004059281,0.00016174602,0.00039873976,0.00236937],"category_scores_gemma":[0.0009945921,0.0001535703,0.00027262833,0.0007376014,0.00023898995,0.000410414,0.00046950654,0.00041044145,0.00018529146],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079554375,0.000044597793,0.9924555,0.000033822056,0.000025307789,0.0012678573,0.0002902788,0.000020311927,0.0003500493,0.0000223221,0.00032829563,0.0050820205],"study_design_scores_gemma":[0.000019074922,0.00017035587,0.9913024,0.00007935433,0.000034786928,0.0066198083,0.00076084933,0.000079843885,0.00011742078,0.00006319979,0.00074798055,0.0000049911137],"about_ca_topic_score_codex":0.0040857038,"about_ca_topic_score_gemma":0.003416271,"teacher_disagreement_score":0.0040857038,"about_ca_system_score_codex":0.00029367954,"about_ca_system_score_gemma":0.00034259248,"threshold_uncertainty_score":0.008123815},"labels":[],"label_agreement":null}]}